Category Archives: Coalition News

CVC Backs Letter Asking MedPAC to Work with Congress to Protect Specialty Care Providers

The letter from USPA describes the need for Congressional hearings to explore long-term Medicare payment solutions

WASHINGTON, DC — Today, the CardioVascular Coalition (CVC) announced it is supporting a letter sent by The United Specialists for Patient Access (USPA) to MedPAC, the Medicare Payment Advisory Commission (MedPAC). The letter outlines how ongoing cuts to office-based specialists under the Physician Fee Schedule are driving closures of community-based specialty care centers and causing a migration of services to higher cost sites-of-service.

Since 2006, specialties such as cardiology, radiology, radiation oncology, vascular surgery and others have been cut by 20-40% under the Physician Fee Schedule. Concurrent with these cuts, there has been an 11% decrease in private practice and an 11% increase in hospital employment or ownership of physician practices.

CLICK HERE TO VIEW THE LETTER

CLICK HERE TO VIEW “FAST FACTS” FROM THE LETTER

Jeffrey G. Carr, MD, an Interventional Cardiologist, Endovascular Specialist, and CVC Board member stated: “We strongly support the message USPA delivered to MedPAC because it relates to our members. Congress needs to step in and stop further cuts to office-based specialty centers from harming patients and forcing providers to close their doors. We also need Congress to focus on long-term solutions to a broken Physician Fee Schedule by working with providers to find solutions that benefit everyone.”

Omnibus Bill Ignores Clinical Labor Cuts and Spells Calamity for Patients

Congress failed to stop cuts in the 2023 Medicare Physician Fee Schedule

Washington, DC — Today, the CardioVascular Coalition (CVC) issued a statement expressing their frustration with the 2023 omnibus spending bill that failed to address the looming clinical labor cuts. The CVC has repeatedly called on Congress to step in and stop the cuts to revascularization services included in the finalized 2023 Medicare Physician Fee Schedule (MPFS) Rule. However, no action was taken.

Jeffrey G. Carr, MD, an Interventional Cardiologist, Endovascular Specialist, and CVC Board member stated:

“The current cuts to clinical labor have brought with them a dreadfully dark outlook for specialty providers across the country. Despite this, Congress chose not to intervene in this issue, and left vulnerable patients on the chopping block. The clinical labor cuts will lead to more unnecessary amputations and force providers to close their doors. To make matters worse, the cuts will worsen health equity problems and accelerate the consolidation trend across the United States. The CVC will continue to be engaged with policymakers regarding this important issue.”

CardioVascular Coalition Demands Congressional Action Before Clinical Labor Cuts Go Into Effect

CVC calls on Congress to stop clinical labor cuts before Dec. 31

Washington, DC— Today, the CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers — is calling on Congress to step in and stop the cuts to revascularization services included in the finalized 2023 Medicare Physician Fee Schedule (MPFS) Rule.

If Congress fails to act before the end of the year, the finalized MPFS will impose cuts of up to 9% on physicians who provide revascularization services in outpatient settings. This care is critical in preventing avoidable amputations and ensuring they receive the care they need.

On top of the long history of MPFS cuts over the last several years, including cuts exceeding 20% from the 2022 PFS / clinical labor policy, these cuts will continue to increase financial pressures on providers at a time of historic economic uncertainty.

If the cuts are left unaddressed, the end result will be providers closing their doors, therefore depriving peripheral artery disease (PAD) patients of care in the outpatient settings they prefer. The CVC believes that the cuts will worsen health equity problems and accelerate the consolidation trend across the United States.

“The sad reality is that these cuts will lead to more unnecessary amputations,” said Interventional Cardiologist and Endovascular Specialist Jeffrey G. Carr, MD, a CVC Board member. “We are asking for Congress to step in and stop these cuts from harming patients and forcing providers to close their doors. There is a bipartisan solution that can pass before the end of the year, but Congress must make this a priority.”

Unless Congress Acts, Ongoing Clinical Labor Cuts Will Worsen Amputation Epidemic

By Paul Gagne, M.D.

There is a little-known epidemic occurring in the medical world that will be made worse if Congress does not act to stop the ongoing clinical labor cuts outlined in the 2023 Medicare Physician Fee Schedule finalized rule.

The amputation epidemic is a troubling trend of preventable leg amputations being performed on patients, particularly people of color. Surgeons perform about 200,000 non-traumatic amputations annually, most of them due to peripheral artery disease (PAD), a common complication of diabetes, kidney disease and chronic hypertension. Some patients also undergo amputation due to long-standing non-healing venous ulcers. As many as 85% of those amputations could be prevented with early diagnostics and treatment.

The final rule for 2023 Medicare Physician Fee Schedule, released by the Centers for Medicare & Medicaid Services (CMS), would impose cuts of up to 9% on doctors in outpatient facilities who provide revascularization services, which are necessary to prevent leg amputation of patients with PAD. As a health care provider, I find this alarming, and I’m calling on Congress to prevent and reverse these cuts. We spend many millions of dollars treating patients who have had amputations addressing their disability, artificial leg needs, progression of other diseases associated with the inability to walk, depression due to loss of independence and the nursing home care necessary when patients lose the ability to care for themselves with loss of ambulation. Much of this could be avoided with patients having a better quality of life if we prevented the amputations. The fee schedule rule would adversely affect important sites of care, namely OBLs, or office based labs, where preventing amputations is our main focus. This is not a task that our post pandemic stretched hospitals can assume. This requires increased access for our most vulnerable patients that is filled by OBLs.

If the cuts are implemented, they will disrupt patients’ access to treatment, lead to higher amputation rates and worsen racial inequities. Revascularization services are not only critical to preventing avoidable amputations for people with PAD, they also often cost less and allow patients to be treated in a more specialized setting.

These cuts come after several years of clinical labor cuts by CMS, some of which caused providers to close their doors, particularly in rural and underserved communities where patients need care the most. If the current Physician Fee Schedule goes forward, patients’ access to revascularization services and other office-based care will be further hurt, and there will be devastating consequences. We will see an increase in amputation and all the associated costs Medicare will need to cover. More importantly, patients’ quality of life will be devastated.

Additionally, the cuts will further overwhelm our already strained hospitals, expose patients to unnecessary health risks and contribute to the trend of health care consolidation. Consolidations have time and again been shown to increase the cost of health care in our communities. It is not good for our patients and citizens.

This is a problem that disproportionately affects communities of color, making this a racial justice issue. According to the Dartmouth Atlas, the risk of amputation for Black Americans with diabetes is as much as four times higher than the national average. Native Americans are more than twice as likely to have an amputation and Hispanics are up to 75% more likely to have an amputation. Minorities are also known to be less likely to pursue hospital care. Losing outpatient options is a challenge to these valued members of our community.

We must prevent amputations through timely care and interventions to reverse end-stage PAD, improve patient’s quality of life, prevent depression due to chronic disability, and prevent chronic pain associated with amputation. We must make our patients’ lives more than figuring out how to live due to limb loss. Patients deserve more than the day-to-day hardship associated with routine tasks of daily living that follows amputation. Our legislators in Washington must step up to help us do that by preventing these cuts and supporting office-based specialists who provide essential services.

I’m calling on Congress to use its power to stop ongoing clinical labor cuts in the 2023 Medicare Physician Fee Schedule final rule. It is crucial to giving patients the appropriate medical care they need to prevent needless amputations, particularly in underserved areas.

Paul J. Gagne MD, FACS, RVT, is board-certified vascular surgeon, fellow of the Society of Vascular Surgery, and director of the Vascular Breakthroughs.

CardioVascular Coalition Calls on Congress, CMS to Stop Proposed MPFS Cuts to Revascularization Services during Peripheral Artery Disease (PAD) Awareness Month

CVC says MPFS cuts make PAD worse and increase amputation rates

Washington, D.C. – Today, the CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) — is again calling on Congress and the Centers for Medicare & Medicaid Services (CMS) to address the significant cuts to revascularization services in the proposed 2023 Medicare Physician Fee Schedule (MPFS) Rule. During PAD Awareness Month, which began on September 1, the CVC hopes to draw attention not only to PAD, and its treatment and prevention, but also to how these cuts will undercut patient access, lead to higher amputation rates, and exacerbate health inequities that already exist.

PAD Awareness Month is a time to reflect on the nearly 20 million Americans impacted by PAD, including an estimated 200,000 individuals who suffer preventable amputations every year due to complications from the chronic disease. Research shows that as many as 85% of amputations could be prevented with access to early diagnostics and appropriate treatment.

If finalized as written, the proposed MPFS would impose cuts of 5%-9% in 2023 on physicians in the outpatient setting who provide revascularization services to these patients and are critical in preventing avoidable amputations. These cuts, on top of the long history of MPFS cuts over the last several years, including clinical labor cuts exceeding 20% in 2022, will continue to increase financial pressures on providers at a time of historic economic uncertainty. This could, in turn, force providers to close their doors, reduce services, and, therefore, deprive PAD patients of care in the outpatient settings they prefer and statistically have better outcomes.

“As we recognize PAD Awareness Month and the major impact that peripheral artery disease has on Americans – particularly people of color – I’m deeply worried about how these proposed cuts would increase instability and further limit patient access to revascularization services that are proven to prevent amputation and reduce costs,” said Interventional Cardiologist and Endovascular Specialist Jeffrey G. Carr, MD, a CVC Board member. “At a time when America is suffering a PAD and amputation crisis, we need to be prioritizing patients, ensuring they have access to the services that are proven to prevent amputations and slow disease progression. Congress and CMS need to act to address these proposed cuts to help providers and stop the spread of health inequity in our country.”

#

CVC Leaders Meet with Policy Makers about New Cuts to Revascularization Services

CVC members join other office-based specialists for virtual lobby day

WASHINGTON, DC — Earlier this week, members of the CardioVascular Coalition from across the country partnered with United Specialists for Patient Access (USPA) to virtually meet with members of Congress about the importance of revascularization services and the proposed changes to the 2023 Medicare Physician Fee Schedule (MPFS).

CVC members shared with policy makers that the repeated cuts to office-based specialists, including those providing revascularization services to the 20 million Americans suffering from Peripheral Artery Disease (PAD), are causing another round of office-based center closures, therefore reducing patient options and increasing costs. Click here to read CVC’s comment letter to the Centers for Medicare and Medicaid Services (CMS).

USPA coalition partners met with over 100 offices during yesterday’s virtual day of action.

“If finalized, the proposed MPFS cuts will undercut access to revascularization services, which are critical to preventing avoidable amputations—especially among communities of color,” said Interventional Cardiologist and Endovascular Specialist Jeffrey G. Carr, MD, a CVC Board member. “The 5-9% cuts proposed by CMS would increase instability and threaten to undercut patient access to the revascularization services that are proven to prevent PAD-related amputations and reduce costs.”

Dr. Carr continued, “We are asking policy makers to reverse these cuts and focus on fundamental reform to the Medicare Physician Fee Schedule that our specialty providers need to survive.”

PAD Task Force Thanks Congressman Payne for Leadership

Payne and PAD Caucus Seek Important RFI during Peripheral Artery Disease Awareness Month

WASHINGTON, D.C. — Today, the Peripheral Artery Disease (PAD) Task Force announced its support for the work being done by Congressman Donald Payne, Jr. (NJ-10) to raise awareness around PAD and his request for information (RFI) related to the Amputation Reduction and Compassion (ARC) Act.

Payne’s RFI seeks input from stakeholders, and the PAD Task Force is encouraging interested parties to respond.

“We are grateful for Congressman Payne’s leadership on PAD and encouraged by the support that the ARC Act is receiving. As we recognize PAD Awareness Month and the major impact that peripheral artery disease has on Americans – particularly people of color – the PAD Task Force is deeply concerned about the health equity gap and limited patient access to revascularization services that are proven to prevent amputation and reduce costs,” said Dr. Foluso Fakorede, a spokesperson for the PAD Task Force.

The PAD Task Force’s mission is to collectively advance a comprehensive strategy that combines increased public awareness and robust screening with non-amputation treatment measures and multidisciplinary care.

CVC to CMS: Ongoing Cuts Undermine Healthcare Access and Quality Care

CVC comment letter highlights concerns over proposed rule

WASHINGTON, DC — Earlier this week, the CardioVascular Coalition (CVC) submitted official comments to the Centers for Medicare and Medicaid Services (CMS) on the proposed rule for the CY 2023

Physician Fee Schedule (CMS-1770-P).

The CVC letter, addressed to CMS Administrator Brooks-LaSure, emphasizes that ongoing cuts to office-based specialists under the Physician Fee Schedule are contributing to office-based center closures, health system consolidation, and a deepening of the existing health equity gaps.

CLICK HERE TO READ THE COMMENT LETTER.

The letter states, in part, “While the [Biden] Administration has launched a number of initiatives aimed at addressing health inequity through the elimination of disparities in health care, the 2023 PFS Proposed Rule actually threatens to undermine these initiatives in areas throughout the PFS by continuing to phase in the 2022 PFS clinical labor cuts.”

It continues, “The incentive is clear for beleaguered PFS providers who may no longer be able to sustain further cuts in the 2023 PFS Proposed Rule to simply close their centers and continue the migration to large health systems. As noted by the Medicare Payment Advisory Commission (MedPAC), ‘the preponderance of evidence suggests that hospital consolidation leads to higher prices.’”

The CVC comment letter goes on to state, “While ‘budget-neutrality’ sounds like good policy, when it operates within a Physician Fee Schedule that has not kept up with inflation, it results in massive swings in reimbursement and punishes providers irrespective of the value they add to the healthcare system. This is because, while reimbursement under the overall Physician Fee Schedule has increased 11 percent over the last two decades, the cost of running a medical practice has increased 39 percent over that same period.”

#

CardioVascular Coalition Opposes Significant Cuts to Revascularization Services in 2023 Medicare Physician Fee Schedule Proposed Rule

If finalized, the proposed 5-9% cuts will undercut access to revascularization services, which are critical to preventing avoidable amputations—especially among communities of color 

Washington, D.C. –– The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today expressed serious concern over proposed cuts included in the 2023 Medicare Physician Fee Schedule (MPFS) Proposed Rule released by the Centers for Medicare & Medicaid Services (CMS). If finalized as written, the proposed MPFS would levy significant cuts of 5-9% in 2023 on physicians in the outpatient setting who provide revascularization services, which are crucial to preventing avoidable amputations for people suffering from peripheral artery disease (PAD).  

The proposed reduction in reimbursement rates is the latest in a troubling trend. There has been a long history of MPFS cuts over the last several years, including clinical labor cuts exceeding 20% in 2022, which have increased financial pressures on providers at a time of historic economic uncertainty. Many providers worry that increased cuts could force them to close their doors or reduce services, which would deprive PAD patients of the care they need in the outpatient setting they prefer, particularly in rural and underserved communities. 

“Facing rising inflation, increasing wages, higher costs, and growing demand for healthcare, and other challenges related to the COVID-19 pandemic, the 5-9% cuts proposed by CMS would increase instability and threaten to undercut patient access to the revascularization services that are proven to prevent amputation and reduce costs. As a result of reduced access, providers fear that fewer Americans will be able to receive the care they need to prevent PAD-related amputations, which disproportionately impact Black, Native, and Hispanic Americans,” said Interventional Cardiologist and Endovascular Specialist Jeffrey G. Carr, MD, a CVC Board member. 

Ensuring access to revascularization services in the patient-preferred community setting is critical. An estimated 20 million Americans are living with PAD, and, approximately 200,000 non-traumatic amputations are performed on people with PAD.  Research shows that as many as 85% of amputations could be prevented with access to early diagnostics and appropriate treatment. 

If cuts like the ones proposed in the 2023 MPFS proposed rule are ultimately implemented, they will undercut patient access, lead to higher amputation rates and exacerbate inequities that already exist, particularly in America’s communities of color. According to the Dartmouth Atlas, amputation risks for African Americans living with diabetes are as much as four times higher than the national average. Data analyses have similarly found that Native Americans are more than twice as likely to be subjected to amputation and Hispanics are up to 75 percent more likely to have an amputation. 

### 

About the CardioVascular Coalition (CVC) 

Our Mission is to advance patient access to care for peripheral artery disease (PAD). Physicians, care providers, advocates, and manufacturers who comprise the CVC are dedicated to community-based solutions designed to improve awareness and prevention of PAD, reduce geographic disparities in access to care, and secure patient access to high-quality, cost-effective interventional treatment across America. Learn more at cardiovascularcoalition.org. 

Contributor: Congress Must Act to Stop America’s Amputation Epidemic

May 16, 2022

Foluso A. Fakorede, MD

The Amputation Reduction and Compassion Act (H.R. 2631) would ensure that Medicare and Medicaid both cover peripheral artery disease screening for at-risk beneficiaries without the cost-sharing requirements that could make some patients balk at seeking care.

As our health care system works to address the many disparities and inequities that Americans of color—particularly Black, Hispanic, and Native Americans—continue to face, there remains too little understanding of our nation’s amputation epidemic. Over the past 2 years, the pandemic has brought attention to the health disparities that continue to affect people from racial and ethnic minority groups. Although some policymakers encourage action through health education, early detection, and control of disease complication, the systematic inequities that result in unnecessary and senseless amputations must be addressed.

Each year, surgeons perform some 200,000 nontraumatic amputations, due primarily to peripheral artery disease (PAD), an all-too-common complication of diabetes, kidney disease, and chronic hypertension. For the 20 million Americans living with PAD, it will become increasingly difficult for oxygen to reach the legs and feet due to plaque building up in a person’s arteries—unless the chronic condition is diagnosed and treated early. Without medical intervention, amputation will become the only option for a high number of individuals, many of whom don’t even find out they have PAD until it’s too late to save their limbs.

Read the full article on AJMC.

As National Minority Health Month Begins, CVC Urges Lawmakers to Support Efforts to Reduce Amputation

CVC commends the Congressional PAD Caucus for recognizing this important health equity issue and urges Congress to pass the ARC Act 

Washington, D.C. –– The CardioVascular Coalition (CVC) – a consortium of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today applauded the Congressional Peripheral Artery Disease (PAD) Caucus for its work highlighting the devastating and disproportionate rates of PAD for Black, Indigenous, and People of Color throughout the United States.  

Peripheral artery disease, an all-too-common complication of diabetes, prevents oxygen in a patients’ bloodstream from reaching their extremities, substantially increasing the risk of requiring amputation. An estimated 20 million Americans are living with PAD, and, approximately 200,000 non-traumatic amputations are performed on people with PAD

Amputation risks for African Americans living with diabetes are three times higher than the national average, according to the Dartmouth Atlas. Research has also found that Native Americans are more than twice as likely to be subjected to amputation and Hispanics are up to 75 percent more likely to have an amputation. Yet, with access to early diagnostics and appropriate treatment, as many as 85% of amputations could be prevented

“For too long, peripheral artery disease has been an under-the-radar epidemic across the United States, particularly in communities of color, making it an important disparity issue that must be addressed,” said Dr. Jeffrey Carr,  an Interventional Cardiologist and Endovascular Specialist and Founding and Immediate Past President of the Outpatient Endovascular and Interventional Society (OEIS). “Sadly, many patients with PAD don’t know they even have the disease until it’s too late to save their limbs from being amputated. In order to prevent avoidable amputation and promote health equity, Congress must pass the Amputation Reduction and Compassion (ARC) Act.” 

The Amputation Reduction and Compassion Act (H.R. 2631) is bipartisan legislation that will enhance access to necessary care by providing coverage of PAD screening for at-risk beneficiaries under the Medicare and Medicaid programs without the imposition of cost-sharing requirements. Introduced by Representative Donald Payne, Jr. (NJ-10) and co-sponsored by 20 bipartisan lawmakers including Representatives Bobby Rush (IL-1), Ruben Gallego (AZ-7), and Jefferson Van Drew (R-NJ), the bill would also disallow payment for non-emergent amputations – unless anatomical testing has been done in the three months prior to amputation – and establish a PAD education program intended to reduce amputations, particularly with respect to the most at-risk populations, including Black, Indigenous, and Hispanic Americans. 

To learn more about the ARC Act, click here. 

### 

About the CardioVascular Coalition (CVC) 

Our Mission is to advance patient access to care for peripheral artery disease (PAD). Physicians, care providers, advocates, and manufacturers who comprise the CVC are dedicated to community-based solutions designed to improve awareness and prevention of PAD, reduce geographic disparities in access to care, and secure patient access to high-quality, cost-effective interventional treatment across America. Learn more at cardiovascularcoalition.org. 

ARC Act 2022

The Amputation Reduction and Compassion (ARC) Act

The CVC is urging support for the Amputation Reduction and Compassion (ARC) Act, sponsored by Congressmen Donald Payne, Jr. (D-NJ), Bobby Rush (D-IL) and Ruben Gallego (D-AZ). The legislation aims to improve peripheral artery disease (PAD) education, increase access to PAD screening, and prevent avoidable lower limb amputations.  

The Amputation Reduction and Compassion (ARC) Act (H.R. 2631) would provide coverage of PAD screening for at-risk beneficiaries under the Medicare and Medicaid programs without the imposition of cost-sharing requirements. 

By expanding coverage for PAD screening, such as the ankle-brachial index test for at-risk beneficiaries, the bill would help prevent vulnerable individuals from developing serious complications from PAD, which can lead to lower limb amputation. While an estimated 20 million Americans have PAD, many are unaware of the serious risks of the disease and are not encouraged to undergo regular screening that could improve patient outcomes and reduce costs to the healthcare system.  

An estimated 200,000 patients – a disproportionate number of whom are minorities – suffer avoidable amputations every year as a result of PAD. 

The ARC Act would prohibit the use of amputation without the completion of arterial testing to determine if alternative interventions could be applied. It would also establish a PAD education program to support, develop, and implement educational initiatives that inform health care professionals and the public about the existence of PAD and methods to reduce amputations, particularly with respect to at-risk populations, such as racial and ethnic minorities who are more likely to face non-traumatic amputation than whites. 

You can support this legislation by asking your Representative to co-sponsor the ARC Act. Send an email now.

Resources

CVC Commends 63 Bipartisan Lawmakers for Urging Congressional Leadership to Provide Office-Based Specialists Relief in Appropriations Package

Washington, D.C. – The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today applauded 63 bipartisan lawmakers in the U.S. House – led by Congressmen Bobby L. Rush (D-IL) and Gus Bilirakis (R-FL) –  for urging Congressional leadership to include relief for office-based specialists in any upcoming omnibus appropriations package.  

In a letter sent to House Speaker Nancy Pelosi, House Minority Leader Kevin McCarthy, Senate Majority Leader Charles Schumer, and Senate Minority Leader Mitch McConnell, the 63 lawmakers voiced their concerns regarding the viability of office-based specialists – including cardiology, radiology, and vascular surgery— given recent changes to the 2022 Physician Fee Schedule. While S.610, the Protecting Medicare and American Farmers from Sequester Cuts Act (PL 117-71), temporarily relieved most of the 3.75 percent cut to the conversion factor scheduled to go into effect on January 1, 2022, lawmakers expressed disappointment that the extensive cuts of more than 20 percent for office-based specialists were left unaddressed.  

“These ‘clinical labor’ cuts are the most significant negative impact of the 2022 Physician Fee Schedule by far and are expected to cut reimbursement by more than 20 percent for some specialties. Frankly, these cuts threaten to undermine efforts to address health inequity, accelerate health system consolidation, and weaken our ability to deal with the pandemic,” the lawmakers wrote. 

The groups on the letter warned that with office-based specialists already seeing 20 to 40 percent cuts since 2006 and the accelerated rate at which hospitals and corporate entities are acquiring physician practices, another round of Physician Fee Schedule cuts will cause many of the remaining office-based centers to close – a potentially leaving Medicare patients with limited access to care. With hospitals overwhelmed with COVID-19 patients, office-based care is critically important for patients dealing with cancer, end-stage renal disease, limb salvage, and other issues. 

“The CVC commends Rep. Rush and Rep. Bilirakis for their continued leadership in addressing these cuts and thanks the 61 other lawmakers in Congress for joining them in urging action to protect office-based specialists and the patient populations they serve in any future omnibus appropriations legislation,” said Interventional Cardiologist and Endovascular Specialist Jeffrey G. Carr, MD, a CVC Board member. 

To read the full letter, CLICK HERE

#### 

About the CardioVascular Coalition (CVC)  

Our mission is to advance patient access to care for peripheral artery disease (PAD). Physicians, care providers, advocates, and manufacturers who comprise the CVC are dedicated to community-based solutions designed to improve awareness and prevention of PAD, reduce geographic disparities in access to care, and secure patient access to high-quality, cost-effective interventional treatment across America. Learn more at cardiovascularcoalition.org.  

The Hill | Congress: To improve health equity, provide relief for office-based specialty care

Just hours after being inaugurated, President Biden signed an executive order commanding the federal government to make racial equity a top priority. Given the stark disparities that continue to plague communities of color—especially when it comes to America’s health care system—this was a welcome first step by the administration.

While the administration’s commitment to health equity is encouraging, regulations from the Centers for Medicare & Medicaid Services (CMS) that were implemented on Jan. 1 seem to contradict this promise just a year after it was made. Despite underserved communities still facing access barriers to health care providers, Medicare slashed funding for specialty care services by upwards of 20 percent. If left in place, these severe cuts will lead to significantly worse health outcomes for Black, Hispanic, and Native Americans—including an increase easily preventable limb amputation.

Click here to see the full article on The Hill.

CVC Commends Congressional Tri-Caucus Lawmakers for Urging Action to Prevent PFS Clinical Labor Policy Updates in 2022

Washington, D.C. –– The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today commended Congressmen Bobby Rush (D-IL), Danny Davis (D-IL), Tony Cardenas (D-CA) and 22 of their colleagues in the Congressional Tri-Caucus for sending a letter to House Speaker Nancy Pelosi (D-CA) urging the inclusion of language in the end-of-the-year legislative package to direct the Centers for Medicare & Medicaid Services (CMS) to not proceed with the implementation of the clinical labor update in the 2022 Physician Fee Schedule (PFS).  The main driver of payment cuts in the 2022 PFS Final Rule are updates to clinical labor data which hit cardiology, vascular surgery, venous, radiation oncology and radiology practices hardest.

“It is clear that any benefits of proceeding with the clinical labor policy at this time are far outweighed by the significantly negative impacts on PFS specialists, which will exacerbate health inequity, drive further health system consolidation, and undermine specialty care. In short, these cuts will harm our nation’s most vulnerable patients and should not be allowed to be implemented,” the lawmakers wrote.

The lawmakers warn that the clinical labor reimbursement cuts of more than 20% to office-based services disproportionately impact minority populations, including seniors diagnosed with peripheral artery disease (PAD) who are at risk for amputation if left untreated. In fact, data show among Medicare beneficiaries diagnosed with PAD, Black patients are three times more likely to receive an amputation and Latino patients are twice as likely. Without access to revascularization services to treat PAD in a less expensive site that is closer to home, patients are at serious risk of limb loss.

“The CardioVascular Coalition applauds Tri-Caucus leaders – including Congressmen Rush, Davis and Cardenas – for leading this effort, and we strongly support the Medicare Stability for Patients and Providers Act (H.R. 6048) as a legislative solution to prevent implementation of the clinical labor cuts on January 1,” said Jeffrey G. Carr, MD, FACC, CVC member and co-founder of the Outpatient Endovascular and Interventional Society (OEIS). “Drastically slashing reimbursements for specialty services most needed by Americans of color would significantly stifle efforts to improve health equity across America. To help protect patient access to these vital services, Congress must act.”

To read the Tri-Caucus letter to Speaker Pelosi, click here.

###

About the CardioVascular Coalition (CVC)

Our mission is to advance patient access to care for peripheral artery disease (PAD). Physicians, care providers, advocates, and manufacturers who comprise the CVC are dedicated to community-based solutions designed to improve awareness and prevention of PAD, reduce geographic disparities in access to care, and secure patient access to high-quality, cost-effective interventional treatment across America. Learn more at cardiovascularcoalition.org.

Endovascular Today: CardioVascular Coalition Applauds Introduction of Medicare Stability for Patients and Providers Act

November 22, 2021—The CardioVascular Coalition (CVC) commended the introduction of the Medicare Stability for Patients and Providers Act (H.R. 6048). The bipartisan legislation, which was sponsored by Representatives Bobby Rush (D-IL) and Gus Bilirakis (R-FL), prohibits the implementation of certain clinical labor price updates included in the Medicare Physician Fee Schedule (PFS) Final Rule for CY 2022.

According to the CVC, the main driver of payment cuts in the 2022 PFS Final Rule is CMS’ updates to clinical labor data. The hardest-hit specialties are cardiology, vascular surgery, venous, radiation oncology, and radiology practices. CVC stated that if left unaddressed, CMS’ changes to the clinical labor policy will result in cuts of up to 22% over 4 years to critical revascularization services at a time when patients are choosing to access health services in outpatient facilities that are convenient and less costly.

Click here to see the full article on Endovascular Today.

CVC Applauds Introduction of Medicare Stability for Patients and Providers Act

Vascular care leaders commend bipartisan legislation to protect patient access to specialty care for Medicare’s most at-risk patients  

Washington, D.C. –– The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today commended the introduction of the Medicare Stability for Patients and Providers Act (H.R. 6048).  The bipartisan legislation – sponsored by Congressmen Bobby Rush (D-IL) and Gus Bilirakis (R-FL) – prohibits the implementation of certain clinical labor price updates included in the Medicare Physician Fee Schedule (PFS) Final Rule for CY 2022. 

The main driver of payment cuts in the 2022 PFS Final Rule is CMS’ updates to clinical labor data. The hardest hit specialties are cardiology, vascular surgery, venous, radiation oncology, and radiology practices. If left unaddressed, CMS’ changes to the clinical labor policy will result in massive cuts of up to 22% over four years to critical revascularization services at a time when patients are choosing to access health services in outpatient facilities that are convenient and less costly. The ability to access revascularization services in a less expensive site that is closer to home can often mean the difference between saving – or amputating – a patient’s lower limb.  

“We applaud Congressmen Rush and Bilirakis for their leadership in sponsoring this legislation to protect patient access to specialty care in the outpatient setting and preserve the stability of independent physician and specialty practices across the country,” said Jeffrey G. Carr, MD, FACC, a CVC member and co-founder of the Outpatient Endovascular and Interventional Society (OEIS). “Bipartisan lawmakers and providers agree that CMS’ clinical labor cuts will do nothing more than limit patient choice, stifle efforts to advance health equity and drive further consolidation of the healthcare marketplace.” 

Limiting patient access to revascularization services for patients living with vascular disease could lead to higher amputation rates and exacerbate inequities that already exist, particularly in America’s communities of color.  According to the Dartmouth Atlas, amputation risks for African Americans living with diabetes are as much as four times higher than the national average.  

On September 13, Representatives Rush, Bilirakis and 73 of their House colleagues sent a letter to CMS urging the agency not to finalize the cuts to specialty care providers included in the proposed 2022 Medicare Physician Fee Schedule (PFS). The lawmakers expressed particular concern on the cuts’ impact on minority health.  

### 

About the CardioVascular Coalition (CVC) 

Our mission is to advance patient access to care for peripheral artery disease (PAD). Physicians, care providers, advocates, and manufacturers who comprise the CVC are dedicated to community-based solutions designed to improve awareness and prevention of PAD, reduce geographic disparities in access to care, and secure patient access to high-quality, cost-effective interventional treatment across America. Learn more at cardiovascularcoalition.org. 

CVC: Clinical Labor Cuts in Final PFS Rule Threaten Patient Access to Amputation Prevention Measures

Vascular care leaders urge Congressional action to prevent implementation of deep Medicare cuts to specialty care services in 2022

Washington, D.C. –– The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – expressed disappointment in the Centers for Medicare & Medicaid Services’ (CMS) Final Physician Fee Schedule (PFS) Rule for CY 2022 that finalizes severe cuts to amputation prevention procedures, including revascularization. The vascular care community plans to immediately seek legislative solutions to ensure these cuts are not implemented as planned in 2022.

“We continue to have significant concerns with the cuts finalized by CMS this week, which we have warned could negatively impact clinical outcomes, limit patient choice, and ultimately drive providers out of business,” said Dr. Jeff Carr, CVC Board Member. “Despite strong, bipartisan opposition to these cuts and the threats they pose to healthcare equality and consolidation, it is upsetting that CMS chose to move forward with these policies. We now look forward to working with our champions in Congress to address these harmful payment cuts before they take effect in 2022.”

On September 13, Representatives Bobby Rush (D-IL), Gus Bilirakis (FL), and 73 of their House colleagues sent a letter to CMS urging the agency not to finalize the cuts to specialty care providers included in the proposed 2022 Medicare Physician Fee Schedule (PFS). The lawmakers expressed particular concern on the cuts’ impact on minority health. According to the letter, cuts of 22% to reimbursement for revascularization services will harm Black and Latino Medicare beneficiaries who are three times more likely and twice as likely, respectively, to receive an amputation due to peripheral artery disease. 

Limiting patient access to revascularization services could lead to higher amputation rates and exacerbate inequities that already exist, particularly in America’s communities of color.  According to the Dartmouth Atlas, amputation risks for African Americans living with diabetes are as much as four times higher than the national average.

The main driver of payment cuts in the 2022 PFS Final Rule are CMS’ updates to clinical labor data. Hardest hit are cardiology, vascular surgery, venous, radiation oncology, and radiology practices. On its face, updating clinical labor data in the CMS database makes sense. Indeed, every specialty under the PFS should be seeing increases to resources based on new clinical data from the Bureau of Labor Statistics. However, including new clinical labor data results in massive cuts of up to 22% over four years to critical revascularization services at a time when patients are choosing to access health services in outpatient facilities that are convenient and less costly. 

###

CVC Commends 75 Bipartisan Members of Congress for Urging CMS to Address Severe Proposed Medicare Cuts

Letter urges CMS to prevent up to 20% cuts by not  finalizing the clinical labor policy in the 2022 Physician Fee Schedule (PFS) proposed rule 

Washington, D.C. –– The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today applauded 75 bipartisan lawmakers in the U.S. House for urging the Centers for Medicare & Medicaid Services (CMS) to address the severe proposed cuts included in the 2022 Physician Fee Schedule (PFS) proposed rule.  

In a letter submitted to CMS Deputy Administrator Dr. Meena Seshamani, 75 bipartisan lawmakers led by Rep. Bobby Rush (D-IL) and Rep. Gus Bilirakis (R-FL), called on CMS to not finalize the clinical labor policy that would cause specialties—including cardiology, radiology and vascular surgery—to face serious cuts of up to 20% in 2022. The proposed cuts, which would be imposed as a direct result of CMS’ “budget neutrality” policy and come on top of years of successive cuts, would be devastating for both patients and providers. Unless CMS reverses course on its proposed clinical labor provision, the lawmakers warned that the severe cuts would accelerate health system consolidation, reduce competition, increase Medicare spending, and exacerbate healthcare inequities for patients of color. To prevent these issues and ensure patients’ access to care, the lawmakers urged CMS to work with Congress on fundamental reforms to the PFS. 

In asking CMS to prevent the severe cuts, the lawmakers expressed particular concern on the proposed rule’s impact on minority health. According to the letter, the 2022 PFS proposed rule threatens to cut reimbursement to revascularization services by 22% despite the fact that Black and Latino Medicare beneficiaries are three times more likely and twice as likely, respectively, to receive an amputation due to peripheral artery disease.  

“Given the strong correlation between ongoing cuts and reimbursement volatility for PFS providers vis-à-vis the health system consolidation trend, we believe the best characterization of the so-called PFS ‘budget neutrality’ provision is that it is a driver of PFS center closures and increased costs to the Medicare program,” the letter stated. The lawmakers went on to note that the cuts may cause “PFS providers who may no longer be able to sustain cuts in the 2022 PFS Proposed Rule to simply close their centers and continue the migration to large health systems.”  

In order to address the severe proposed cuts, the lawmakers strongly recommended CMS not finalize the clinical labor policy in the 2022 PFS Final Rule. In addition, they urged CMS to work closely with Congress on reforming the PFS system in order to address a scheduled 3.75 percent 

cut to the conversion factor in 2022, which also threatens provider stability.  

To read the text of the letter, CLICK HERE

### 

About the CardioVascular Coalition (CVC) 

Our Mission is to advance patient access to care for peripheral artery disease (PAD). Physicians, care providers, advocates, and manufacturers who comprise the CVC are dedicated to community-based solutions designed to improve awareness and prevention of PAD, reduce geographic disparities in access to care, and secure patient access to high-quality, cost-effective interventional treatment across America. Learn more at cardiovascularcoalition.org. 

Coalition Urges CMS to Not Finalize Clinical Labor Policy in 2022 PFS Proposed Rule

Unless CMS and Congress take action, proposed cuts of an estimated 23% will drive healthcare consolidation, increase costs, and exacerbate healthcare inequities  

Washington, D.C. –– A group of 16 influential professional groups and societies representing providers across the specialty provider space – including the CardioVascular Coalition – are urging the Centers for Medicare & Medicaid Services (CMS) to not finalize the clinical labor policy included in the 2022 Physician Fee Schedule (PFS) proposed rule.  

As a direct result of CMS’ “budget neutrality” policy, several specialty providers, including providers of revascularization services, face troubling cuts of an estimated 23% — a major blow that comes on top of years of successive, cumulative cuts and amid a historic pandemic that continues to disrupt patient care. To ensure access to specialty care, the groups are asking CMS to address the cuts by not finalizing the clinical labor policy included in the 2022 PFS proposed rule and by coordinating with Congress on fundamental reform to the PFS through legislation this year. 

If left unaddressed, some organizations warn that the massive, proposed cuts would have serious implications including higher costs, increased consolidation among health providers, decreased competition, more volatility, and exacerbated disparities for communities of color.  

“Successive, cumulative cuts to specialists under the PFS are resulting in reimbursement ever more out of touch with actual resource needs as well as increased healthcare consolidation and healthcare costs, greater health inequities, and a healthcare system unable to meet the challenges of an ongoing pandemic,” a United Specialists for Patient Access (USPA) stakeholder letter signed by the CVC stated. 

To address the proposed cuts, the organizations call on CMS to not update clinical labor data in the 2022 PFS final rule, which would automatically invoke the budget neutrality provision and cause severe cuts of more than 20% to critical services under the PFS system. Additionally, the organizations urged CMS to work with Congress to fundamentally reform the PFS so that the “budget neutrality” provision in the 2021 PFS Final Rule E/M policy cannot continue causing negative impacts in the form of a scheduled 3.75% cut to the conversion factor in 2022. 

Groups opposing CMS’ clinical labor proposal include: 

  • American College of Radiation Oncology 
  • American Society of Diagnostic and Interventional Nephrology  
  • American Vein & Lymphatic Society 
  • American Venous Forum 
  • Alliance for Physical Therapy Quality and Innovation  
  • Association of Black Cardiologists 
  • CardioVascular Coalition 
  • Dialysis Vascular Access Coalition 
  • The Fibroid Coalition 
  • Outpatient Endovascular and Interventional Society 
  • Preventive Cardiovascular Nurses Association 
  • Renal Physicians Association 
  • Society for Cardiovascular Angiography & Interventions  
  • Society of Interventional Radiology 
  • Society for Vascular Medicine 
  • United Specialists for Patient Access 

To read the USPA coalition letter, CLICK HERE

### 

About the CardioVascular Coalition (CVC) 

Our Mission is to advance patient access to care for peripheral artery disease (PAD). Physicians, care providers, advocates, and manufacturers who comprise the CVC are dedicated to community-based solutions designed to improve awareness and prevention of PAD, reduce geographic disparities in access to care, and secure patient access to high-quality, cost-effective interventional treatment across America. Learn more at cardiovascularcoalition.org. 

Cardiovascular Coalition Urges Congress, CMS to Reverse Proposed Medicare Cuts During Peripheral Artery Disease (PAD) Awareness Month

If finalized, the proposed ~23% cuts would have a devastating impact on patient access and systemic disparities by accelerating America’s amputation epidemic

Washington, D.C. –– The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today called on Congress and the Centers for Medicare & Medicaid Services (CMS) to address severe proposed cuts to specialty provider services in order to help increase access to care. As Peripheral Artery Disease (PAD) Awareness Month begins today, it is a time to reflect on the nearly 20 million Americans impacted by PAD, including an estimated 200,000 individuals who suffer preventable amputations every year due to complications from the chronic disease, and to ensure patients’ access to vascular care that is shown to improve quality of life, reduce care costs, and prevent limb loss.

CMS recently proposed cutting payments for revascularization services by approximately 23% in the proposed Physician Fee Schedule (PFS) Rule for CY2022. The proposed cuts, which are being driven by a provision that purports to update clinical labor data, would have a severe impact on cardiology, vascular surgery, venous, radiation oncology, and radiology practices. Though outpatient health services – including revascularization – are cost-effective and convenient for patients, the proposed cuts would have profoundly negative effects on patient access and health equity. If the proposed cuts are finalized as currently proposed, Medicare beneficiaries will face more serious risks of limb loss.

“As we recognize PAD Awareness Month and the major impact that peripheral artery disease has on Americans – particularly people of color – I’m deeply troubled by CMS’ flawed proposal to cut vital services like revascularization by as much as 23%,” said Dr. Jeff Carr, CVC Board Member. “At a time when America is suffering a PAD and amputation crisis on top of the COVID-19 pandemic, it is absolutely critical to ensure patients’ continued access to the services that are proven to help prevent amputations and slow disease progression. Unless Congress and CMS act to address these proposed cuts, I fear that it will be harder for patients to access necessary care, resulting in even more amputations, worse outcomes, and even greater healthcare disparities.”

According to estimates, PAD affects nearly 20 million Americans and is responsible for 80 percent of the 200,000 non-traumatic limb amputations that take place in the U.S. each year. These non-traumatic amputations often occur without any diagnostic testing, meaning PAD patients are losing limbs before they receive testing to determine if limb-saving interventions are an option.

PAD is exacerbated by conditions like diabetes, chronic hypertension, and renal disease, which are most prevalent in minority populations. Access to revascularization therapies is especially vital to the African American, Hispanic, and Native American populations who are two to four times more likely to undergo a limb amputation due to PAD because of the increased prevalence of diabetes, obesity, and other risk factors.

“To address the issues of patient access and systemic health inequity in our country, CMS must reverse course and not finalize the clinical labor policy in the 2022 PFS Proposed Rule,” continued Dr. Carr. “Further, CMS should work closely with Congress to fundamentally reform the Physician Fee Schedule so that any future unjustified cuts to specialty provider services can be avoided.”

To learn more about PAD and PAD Awareness Month, CLICK HERE.

###

About the CardioVascular Coalition (CVC)

Our Mission is to advance patient access to care for peripheral artery disease (PAD). Physicians, care providers, advocates, and manufacturers who comprise the CVC are dedicated to community-based solutions designed to improve awareness and prevention of PAD, reduce geographic disparities in access to care, and secure patient access to high-quality, cost-effective interventional treatment across America. Learn more at cardiovascularcoalition.org.

CardioVascular Coalition Notes Proposed 20% Medicare Cut to Amputation Prevention Services Will Increase Health Inequity

Deep payment cuts proposed by the Centers for Medicare & Medicaid Services (CMS) threatens to reduce access to Medicare beneficiaries at risk for limb loss 

Washington, D.C. –– The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – expressed grave concern regarding deep ~20% payment cuts to revascularization services in the proposed Physician Fee Schedule (PFS) Rule for CY2022.   

“Revascularization services that treat blood flow to legs and feet are absolutely vital for older Americans at risk of severe arterial blockages and limb loss,” said Dr. Jeff Carr, CVC Board Member. “CMS’ proposed cuts, despite the well-documented improvement in clinical outcomes resulting from revascularization performed in the outpatient setting, are severe, unwarranted, and may limit patient choice, and threaten to drive providers out of business. If the proposed 20% cut is finalized by the agency, the downstream effects on patient access, health system consolidation, and systemic inequities will be devastating.” 

The main driver of payment cuts in the 2022 PFS Proposed Rule relates to a CMS proposal to update clinical labor data.  Hardest hit are cardiology, vascular surgery, venous, radiation oncology, and radiology practices. On its face, updating clinical labor data in the CMS database makes sense. 

Indeed, every specialty under the PFS should be seeing increases to resources based on new clinical data from the Bureau of Labor Statistics.  However, including new clinical labor data results in massive cuts of up to 20% to critical revascularization services at a time when patients are choosing to access health services in outpatient facilities that are convenient and less costly.   

These impacts will have profoundly negative effects on health equity.  The decrease in access to revascularization services could lead to higher amputation rates and exacerbate inequities that already exist, particularly in America’s communities of color.  According to the Dartmouth Atlas, amputation risks for African Americans living with diabetes are as much as four times higher than the national average. Data analyses have similarly found that Native Americans are more than twice as likely to be subjected to amputation and Hispanics are up to 75 percent more likely to have an amputation. 

“As frontline medical professionals dedicated to improving access to quality vascular care, we strongly urge CMS not to finalize the clinical labor policy in the 2022 PFS Proposed Rule as the second-order negative impacts far outweigh any benefit from updated clinical labor data at this time,” continued Dr. Jeff Carr.  “Moreover, considering the 2021 PFS Final Rule E/M scheduled 3.75 percent cut to the conversion factor is still causing negative impacts in 2022, we urge CMS to work with Congress on fundamental reform to the PFS in order that Congress may better address the upcoming 3.75 percent cut in legislation later this year.” 

### 

About the CardioVascular Coalition (CVC) 

Our mission is to advance patient access to care for peripheral artery disease (PAD). Physicians, care providers, advocates, and manufacturers who comprise the CVC are dedicated to community-based solutions designed to improve awareness and prevention of PAD, reduce geographic disparities in access to care, and secure patient access to high-quality, cost-effective interventional treatment across America. Learn more at cardiovascularcoalition.org. 

PAD Task Force Commends Reintroduction of ARC Act in the U.S. in Recognition of National Minority Health Month

H.R. 2631 will increase education and screening for at-risk populations in order to reduce limb loss

WASHINGTON – Members of the Peripheral Artery Disease (PAD) Task Force – including the Association of Black Cardiologists (ABC), CardioVascular Coalition, CLI Global Society, Preventative Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions and Society of Interventional Radiology – today commended introduction of the Amputation Reduction and Compassion (ARC) Act (H.R. 2631), legislation intended to reduce unnecessary amputations due to peripheral artery disease. The bill, introduced by Representative Donald Payne, Jr. (NJ-10) along with original co-sponsors Representatives Jeff Van Drew (R-NJ), Bobby Rush (D-IL), Ruben Gallego (D-AZ), Mark Takano (D-CA), Raul Grijalva (D-AZ), Katie Porter (D-CA), Darren Soto (D-FL), G.K. Butterfield (D-NC), Ayanna Pressley (D-MA), and Albio Sires (D-NJ), provides coverage of PAD screening for at-risk beneficiaries under the Medicare and Medicaid programs without the imposition of cost-sharing requirements.

In order to encourage appropriate screening and early detection of dangerous complications, the ARC Act further disallows payment for non-emergent amputations – unless anatomic testing has been done in the three months prior to amputation. The legislation also provides resources for a PAD education program to support, develop, and implement educational initiatives that inform health care professionals and the public about PAD- as well as methods to reduce amputations, particularly with respect to at-risk populations including racial and ethnic minorities.

“The ARC Act is a historic intervention destined to alter the cardiovascular health outcomes of at-risk PAD patients and address the virulent practice of PAD-related amputations,” Foluso Fakorede, MD, Co-chair of the ABC PAD Initiative. “The ABC welcomes this bipartisan effort and implementation of policy action in hopes of achieving genuine health equity.”

“With the introduction of the ARC Act, and in recognition of National Minority Health Month, we have the opportunity to expand coverage for simple, non-invasive screening tests that will empower patients to take steps to manage their peripheral artery disease before amputation becomes necessary,” said Dr. Jeffrey Carr co-founder of the Outpatient Endovascular and Interventional Society (OEIS) and a member of the CardioVascular Coalition.

“The ARC Act constitutes an important step towards preventing unnecessary amputations related to PAD,” said Dr. Lola Coke, a cardiovascular clinical nurse specialist with the Preventive Cardiovascular Nurses Association. “By expanding coverage for screening tests and supporting public and provider education especially in high risk patients like chronic smokers and diabetics, we have the opportunity to minimize the progression of the disease and save limbs for those diagnosed with PAD.“

“Approximately 20 million Americans have peripheral artery disease (PAD) and an estimated 200,000 of them – disproportionately from minority communities – suffer unnecessary amputations every year. The Society for Cardiovascular Angiography and Interventions (SCAI) supports this bill because we believe 200,000 is too many,” said Joaquin Cigarroa, MD, SCAI Government Relations Committee chair.   

“Patients deserve to know and have access to all treatment options. With non-invasive screenings, the ARC Act will empower patients to make informed decisions about their peripheral artery disease treatment. The earlier we are able to catch and treat PAD, the more likely we are able to avoid amputations and preserve patients’ quality of life,” said SIR President Matthew S. Johnson, MD, FSIR, an interventional radiologist and Gary J. Becker Professor of Radiology Research at Indiana University School of Medicine in Indianapolis.

Minority populations in the U.S. are at disproportionately higher risk for amputations from PAD. According to data compiled by the Dartmouth Atlas of Health Care, Black Americans are over three times more likely than Whites to experience a non-traumatic amputation as a result of diabetes, a common PAD risk factor. Similarly, Native Americans are more than twice as likely to be subjected to amputation, while Hispanics are up to 75 percent more likely to have an amputation.

Congressmen Donald Payne, Jr. (D-NJ) and Gus Bilirakis (R-FL) formed the Congressional PAD Caucus in 2019 to educate Congress and communities about PAD in order to ensure increased PAD awareness, better access to PAD screening, and the prevention of non-traumatic amputations through the use of anatomical testing.

The PAD Task Force, originally formed in 2018, came together to advance strategies to increase public awareness and robust screening to ensure non-amputation treatment measures through a multidisciplinary team care approach.  The PAD Task Force notes that its concerns around PAD are not restricted to government programs and urges private payers to also adopt policies to raise awareness about PAD, improve access to PAD screening, and disallow non-traumatic amputations without anatomical testing.

PAD is a limb-threatening circulatory condition, which when left undiagnosed and untreated, can result in lower-limb amputation. It is exacerbated by conditions like diabetes, chronic hypertension, and renal disease, which are disproportionately prevalent in minority populations. According to estimates, PAD results in as many as 200,000 amputations annually in the United States. These non-traumatic amputations often occur without any diagnostic testing, which indicates that many PAD patients are losing limbs before they receive the appropriate testing to determine if limb-saving treatments are an option.

To learn more about the ARC Act, click here.

####

CardioVascular Coalition Applauds Introduction of Bipartisan Bill to Prevent Amputations, Increase PAD Screening & Improve Education

Amputation Reduction and Compassion Act, introduced in recognition of National Minority Health Month, will expand coverage for PAD screening among at-risk populations

Washington, D.C. –– The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today applauded lawmakers in Congress for re-introducing the Amputation Reduction and Compassion (ARC) Act (H.R. 2631), bipartisan legislation to improve peripheral artery disease (PAD) education, increase access to PAD screening and reduce lower limb amputations.  The bill would provide coverage of PAD screening for at-risk beneficiaries under the Medicare and Medicaid programs without the imposition of cost-sharing requirements, thereby ensuring early detection and intervention to prevent amputation. 

The bill is sponsored by Representative Donald M. Payne, Jr. (D-NJ) and originally co-sponsored by Representatives Jeff Van Drew (R-NJ), Ruben Gallego (D-AZ), Bobby L. Rush (D-IL), Mark Takano (D-CA), Raúl M. Grijalva (D-AZ), Katie Porter (D-CA), Darren Soto (D-FL), G.K. Butterfield (D-NC), Ayanna Pressley (D-MA) and Albio Sires (D-NJ).

By expanding coverage for PAD screening for at-risk beneficiaries, the bipartisan bill would help prevent vulnerable individuals from developing serious complications from PAD, which can lead to lower limb amputation. To reduce unnecessary limb loss, the ARC Act would prohibit reimbursement for amputation unless arterial testing was previously carried out to determine if alternative interventions could be applied. Further, the bill would establish a PAD education program to support, develop, and implement awareness initiatives that inform health care professionals and the public about the dangers of PAD and methods to reduce amputation. This is especially important with respect to at-risk populations, including racial and ethnic minorities who are more likely to face non-traumatic amputation than whites.

While an estimated 20 million Americans have PAD, many are unaware of the serious risks of the disease and are not encouraged to undergo preventative tests that could save their limbs, improve patient outcomes, and reduce costs to the healthcare system. Data suggest an estimated 200,000 patients – a disproportionate number of whom are people of color – suffer non-traumatic amputations each year. Yet, with access to timely screening and proper care, as many as 85% of those amputations can be prevented.

“With the introduction of the ARC Act we have the opportunity to expand coverage for simple, non-invasive screening tests that will empower patients to more effectively manage their PAD before amputation becomes necessary,” said Dr. Jeffrey Carr, co-founder of the Outpatient Endovascular and Interventional Society (OEIS) and a member of the CVC. “Amputation should be a last resort, yet research shows that most non-traumatic amputations can be prevented with access to early screening and detection—underscoring the need for increased access and coverage. We applaud these bipartisan lawmakers for introducing this critical legislation, which will go a long way toward saving lives and limbs, particularly in communities of color who bear the brunt of the PAD crisis.”

According to the Dartmouth Atlas, amputation risks for African Americans living with diabetes are as much as four times higher than the national average. Similarly, that Native Americans are more than twice as likely to be require amputation related to PAD, while Hispanics are up to 75 percent more likely to have an amputation.

“As the PAD crisis continues to ravage the country, especially among communities of color who are the most at-risk for amputation, we urge Congress to quickly pass the ARC Act,” added Carr. “As we recognize National Minority Health Month this April, we look forward to supporting this bipartisan bill and working collaboratively with lawmakers, advocates, patients, and physicians to address health inequities that persist in America today.”

###

CardioVascular Coalition Applauds Bipartisan Congressional Letter Urging National Effort to Prevent Amputations

Lawmakers Urge President Biden to Prioritize Amputation Prevention Strategies and Invest in Preventative Care to Reduce Incidence and Harm of Vascular Disease

WASHINGTON – The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today commended Members of Congress for urging President Joe Biden and his Administration to support greater efforts to prevent unnecessary amputations in the United States.

In a letter signed by 16 bipartisan lawmakers, the group highlighted the risks of untreated peripheral artery disease (PAD) which lead to amputation, an issue that disproportionately impacts communities of color. To prevent thousands of unnecessary amputations from taking place every year, the lawmakers called on President Biden to prioritize amputation prevention as a vital form of preventive care by bringing policies at both the U.S. Department of Health and Human Services and the National Institutes of Health in line with a strategy to prevent unnecessary amputations.

The letter was organized by Congressman Donald M. Payne, Jr. (D-NJ), Chairman of the Congressional PAD Caucus which was formed to educate Congress and communities about PAD while supporting legislative activities to improve PAD research, education, and treatment, with the goal of preventing non-traumatic amputations due to PAD and other related diseases.

In addition to Congressman Donald M. Payne, Jr., the letter was signed by Representatives Gus M. Bilirakis (FL-12), Ruben Gallego (AZ-7), Barbara Lee (CA-13), Alcee L. Hastings (FL-20), Nanette Diaz Barragán (CA-44), Sanford D. Bishop, Jr. (GA-20), André Carson (IN-7), Lisa Blunt Rochester (D-At Large), Henry C. “Hank” Johnson, Jr. (GA-4), Katie Porter (CA-45), Marilyn Strickland (WA-10), Jenniffer González-Colón (PR-At Large), Eleanor Holmes Norton (DC-At Large), Sheila Jackson Lee (TX-18) and Linda T. Sánchez (CA-38).

“While an estimated 200,000 Americans have their limbs surgically removed every year due to complications from peripheral artery disease – particularly in Black, Native American, and Hispanic communities – we know that preventative care and early screening can help Americans avoid amputation and live longer, healthier lives,” said Dr. Jeffrey Carr, co-founder of the Outpatient Endovascular and Interventional Society (OEIS) and a member of the CVC. “We commend Representative Payne for his leadership and all the lawmakers who signed this letter for their commitment to ensuring Americans at high risk of amputation can access the preventative and interventional care they need.”

“Federal healthcare spending should incentivize preventative screenings for high-risk individuals so that PAD can be caught and treated early, before it leads to amputation and discouraging non-traumatic amputations if anatomical testing is not performed first,” the lawmakers wrote to President Biden. “The U.S. Department of Health and Human Services should work with providers to establish quality measures to reduce avoidable amputations. On the research side, the National Institutes of Health should work with doctors to increase awareness of PAD and PAD symptoms, which will help them quickly and accurately diagnose this disease and begin treatments.”

As many as 85% of the nation’s 200,000 non-traumatic amputations could be prevented with access to early detection and preventative testing. By screening for symptoms such as critical limb ischemia, the likelihood of an individual needing a PAD-related amputation can be reduced by up to 90%. Unfortunately, too few Americans are offered routine screening for PAD. As a result, many do not know they even have the disease until it is too late to prevent amputation. This is problem is particularly acute in communities of color. For example, Black American patients are up to four times more likely to have their limbs surgically removed than their white counterparts due to advanced peripheral artery PAD.

###

CardioVascular Coalition Thanks Congress for Easing Specialty Payment Cuts

End-Of-Year Spending Package is Good First Step by Providing One-Year, 3.75% Increase to the Physician Fee Schedule, Delaying Add-On Code for Three Years

WASHINGTON – The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today commended Congress for taking action to ease the severe Medicare payment cuts that were set to go into effect on January 1.  In the end-of-year spending package that passed with strong bipartisan support, Congress delayed the reimbursement cuts and added $3 billion in funding into the CY2021 Medicare Physician Fee Schedule (PFS), reducing cuts to vascular surgery, cardiac surgery, and interventional radiology by approximately two-thirds. The legislative package also suspends the 2 percent sequester cuts for three additional months.

While a temporary fix that does not fully eliminate the PFS cuts in 2021, this legislation will offer much-needed relief to the more than 30 specialty providers slated for deep reimbursement reductions.  If implemented as scheduled, the cuts to “vascular surgery” (-7%), “cardiac surgery,” (-9%) and “interventional radiology” (-9%) would have hampered providers’ ability to remain stable during the ongoing COVID-19 public health emergency.

“Recognizing the severe strain that specialty providers are facing, we are pleased that Congress took decisive action to ease the deep Medicare cuts slated to go into effect on January 1,” said Dr. Jeffrey Carr, co-founder of the Outpatient Endovascular and Interventional Society (OEIS) and a member of the CVC. “Healthcare practitioners who offer specialty services – including vascular surgery, cardiac surgery, and interventional radiology – will be in a better position in 2021 to preserve continued patient access to the care they need, especially during the COVID-19 pandemic.  However, we know there is still more work to be done and we look forward to working with Congress and the Administration next year to further advance policies that will provide payment stability to PFS services over the long-run.”

###

CardioVascular Coalition Expresses Concern with CMS Decision to Finalize Deep Cuts to Specialty Services Despite COVID-19 Pandemic, Widespread Opposition

Vascular care providers call on Congress to pass legislation in year-end package to block 2021 payment cuts and protect patient access to specialty care

WASHINGTON – The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today expressed disappointment in the Centers for Medicare & Medicaid Services’ (CMS) decision to finalize deep cuts to specialty providers in the Final Physician Fee Schedule Rule for CY2021.

Despite vocal opposition from patients, providers, and bipartisan lawmakers, CMS’ decision to slash Medicare reimbursement rates for “vascular surgery” (-7%), “cardiac surgery,” (-9%) and “interventional radiology” (-9%) – among other specialties – undercuts providers’ ability to remain viable during the unpredictable COVID-19 pandemic. If not addressed by Congress before the PFS rule goes into effect on January 1, 2021, these devastating cuts will ultimately impact patient access to the vital specialty services they need.

“The severe Medicare cuts finalized by CMS are deeply troubling for both patients and providers,” said Dr. Jeffrey Carr, co-founder of the Outpatient Endovascular and Interventional Society (OEIS) and a member of the CVC. “With America’s healthcare system under unprecedented stress by the COVID-19 pandemic, now is the absolute worst time to push through new payment cuts. In order to protect patients’ continued access to specialty services, we urge Congress to advance a legislative solution in the next relevant year-end legislative package.”

Bipartisan Members of Congress have consistently spoken out against the now-finalized cuts, introducing two pieces of legislation to address the cuts, H.R. 8702 and H.R. 8505, which would both provide a necessary reprieve for the dozens of specialty providers that are scheduled to see reimbursement reductions in 2021. The CVC supports legislative action to protect a wide array of specialties including “vascular surgery,” “cardiac surgery,” and “interventional radiology” from being cut without affecting the much-needed payment increases for evaluation and management (E/M) services from going into effect.

“The clock is ticking. Without quick Congressional action, these deep cuts will start impacting America’s specialty providers on January 1,” continued Dr. Carr. “In the interest of protecting Medicare beneficiaries’ health and safety—especially during the ongoing COVID-19 public health emergency—we urge Congress to swiftly pass legislation to stop these harmful cuts.”

###

Vascular Care Leaders Commend Lawmakers for Supporting Legislation to Address Dramatic Payment Cuts in 2021 Medicare Physician Fee Schedule Rule

Despite Congressional and stakeholder opposition, the Centers for Medicare & Medicaid Services finalized sharp payment cuts to specialty providers including vascular surgery, cardiac surgery and interventional radiology

Washington, D.C. – The CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – commends bipartisan lawmakers in both chambers of Congress for recently sending a series of letters to House and Senate leadership urging support for legislation to address deep payment cuts to specialty providers in the CY2021 Medicare Physician Fee Schedule (PFS).

Specifically, 50 Members of the U.S.  Senate, 26 Members of the Congressional Black Caucus and 19 physicians in the U.S. House of Representatives united to urge Congressional leaders to include legislation in any end-of-the-year legislative package to protect American seniors and our nation’s healthcare system by blocking planned cuts to more than 30 specialty provider services scheduled to take effect January 1, 2021. 

Despite thousands of comments opposing the cuts made by providers, patients and bipartisan Members of Congress, Medicare maintained harmful cuts in the final PFS rule for 2021, including cuts to  “vascular surgery” by -7%, “cardiac surgery” by -9% and “interventional radiology” by -9%.

Two pieces of bipartisan legislation have been introduced in the U.S. House of Representatives to mitigate the cuts, including H.R. 8702, which would hold any codes receiving a cut harmless for two years, and H.R. 8505, which would provide a one-year waiver of budget neutrality adjustments under the PFS.

The bipartisan group of Senators, led by Sens. Steve Daines (R-MT) and Debbie Stabenow (D-MI),  asserts, “The payment cuts proposed by CMS would pose a threat to providers and their patients under any circumstances, but during a pandemic the impact is even more profound.”

In expressing their opposition to the sharp specialty provider cuts, the Congressional Black Caucus (CBC) lawmakers wrote, “We are aware of solutions to either waive budget neutrality requirements (H.R. 8505) or to hold specialists harmless (H.R. 8702). While not perfect, either of these solutions would give healthcare specialists the financial security they need to weather the COVID-19 pandemic. As such, we urge you to include a provision in the end of year spending package to prevent these reckless cuts from taking effect, while allowing the increases to proceed as scheduled on January 1, 2021.”

In their letter to leadership, the House physicians added, “As Members of Congress who directly care for patients, we understand the consequences that the upcoming reimbursement cuts will have on patient care and patient access to care. We look forward to working with you to prevent the harm that will inevitably arise if the impending cuts in the PFS go into effect on January 1, 2021.”

To view the Senate letter, click here.

To view the CBC letter, click here.

To view the House physician letter, click here.

###

CVC Urges Lawmakers to Support Peripheral Artery Disease (PAD) Testing and Education During American Diabetes Month

Amputation Reduction and Compassion (ARC) Act supports patient education and screening of at-risk populations to reduce lower limb amputation

Washington, D.C. – In recognition of American Diabetes Month, the CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – is urging lawmakers in Congress to support the Amputation Reduction and Compassion (ARC) Act (H.R. 8615), legislation to expand education and screening for peripheral artery disease (PAD).  PAD is a vascular disease that is often associated with diabetes and other related co-morbidities.

The ARC Act was introduced last month by Representative Donald Payne, Jr. (NJ-10) and co-sponsored by Reps. Bobby Rush (IL-01) and Ruben Gallego (AZ-7), to reduce amputations and close the racial disparities gap in PAD by increasing screening and education.  The bill calls for Medicare and Medicaid coverage to include PAD screening tests and policies to prevent medical providers from being reimbursed for amputation procedures without first completing arterial testing. The ARC Act would also establish educational initiatives that inform health care professionals and the public about peripheral artery disease and the importance of early detection.

More than 34.2 million Americans have diabetes, and an additional 88 million more are pre-diabetic, putting them at a higher risk for developing PAD. PAD is responsible for more than 80% of non-traumatic lower limb amputations in the U.S. each year, many of which could be avoided with appropriate screening and intervention.  Early PAD screening has proven to reduce the probability of an amputation resulting from PAD by 90 percent, underscoring the critical importance of policies to expand patient access to screening to reduce the occurrence of amputation in the U.S.

Unfortunately, PAD-related amputations occur more frequently among minority communities. Research shows that right now, Black Americans with diabetes are up to four times more likely to undergo an amputation as a consequence of PAD compared to white Americans.  Similarly, Hispanic and Native Americans with diabetes experience PAD at a measurably higher rates than white Americans.

“We commend Rep. Donald R. Payne, Jr. and his co-sponsors, Rep. Ruben Gallego and Rep. Bobby Rush, for their leadership on this issue,” said Dr. Jeffrey Carr, founding and past president of the Outpatient Endovascular and Interventional Society (OEIS) and a member of the CVC. “We hope lawmakers in Congress will support H.R. 8615 to bring early screening to America’s most high-risk individuals, including those who are diabetic and pre-diabetic.”

###

CardioVascular Coalition Commends Bipartisan Congressional Letter to House Leadership Urging Action on Pending Healthcare Cuts

229 bipartisan lawmakers join growing chorus of leaders opposing Medicare specialty cuts  

Washington, D.C. – Today the CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – applauded a bipartisan letter signed by 229 Congressional lawmakers – led by Reps. Larry Bucshon, MD (IN-8) and Ami Bera (CA-7) – urging House leadership to take action to prevent or mitigate significant provider payment cuts included in the Medicare Physician Fee Schedule (PFS) Proposed Rule for 2021.

“Over the past eight months, specialty providers have grappled with historic operational and financial challenges, which have made it increasingly difficult to remain sustainable,” said Jeffrey Carr, MD, a CVC member. “As the COVID-19 pandemic continues into next year, saddling already beleaguered providers with steep payment cuts will only serve to destabilize America’s healthcare marketplace and undermine patient access to critical care services.”

Issued on August 3rd, the PFS Proposed Rule for CY2021 would impose deep payment cuts to 33 specialty providers – including “vascular surgery,” “cardiac surgery,” and “interventional radiology” – in 2021. Specifically, Medicare plans to cut “vascular surgery” by seven percent (-7%), “cardiac surgery,” by nine percent (-9%) and “interventional radiology” by nine percent (-9%).

As the letter notes, “specialists now face substantial cuts beginning on January 1, 2021, if Congress does not act before the end of the year. Payment cuts of this magnitude will surely strain a health care system that is already stressed by the COVID-19 pandemic and could jeopardize patient access to medically necessary services.”

“We commend these lawmakers for fighting on behalf of specialty care providers and the patients they serve,” Carr concluded. “We urge House leadership to take immediate action to protect this critical pillar of America’s healthcare infrastructure.”

To read the Bucshon-Bera letter, CLICK HERE.

###

Vascular Care Leaders Applaud Rep. Donald Payne, Jr. for Introducing Bill to Address Health Inequities in Peripheral Artery Disease

The Amputation Reduction and Compassion (ARC) Act aims to prevent amputations by expanding Medicare and Medicaid coverage for PAD and establishing a PAD education program

Washington, D.C. – Today the CardioVascular Coalition (CVC) – a coalition of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – thanked Representative Donald Payne, Jr. (D-NJ) for his exemplary leadership and commitment to addressing the inequities and health disparities plaguing our healthcare system by introducing The Amputation Reduction and Compassion (ARC) Act (H.R. 8615).

If passed, the ARC Act would expand Medicare and Medicaid coverage to include PAD screening tests, while also preventing reimbursement for amputation without the prior arterial testing that could potentially mitigate complications and prevent amputation. In addition to expanding access to PAD screening tests, the ARC Act would establish a program to help develop, support, and implement educational initiatives that inform health care professionals and the public about the existence of peripheral artery disease and the importance of early detection.

The ARC Act demonstrates Rep. Payne’s continued dedication to creating an equitable healthcare system, which began when he co-founded the Congressional PAD Caucus with Rep. Gus Bilirakis (R-FL) in April 2019. The PAD Caucus seeks to educate Congress about PAD while supporting legislative activities to improve PAD research, education, and treatment.

Providing adequate healthcare for vulnerable individuals is essential, particularly those most at risk for PAD. Today, an estimated 21 million Americans have PAD, and an estimated 200,000 of them are at risk of undergoing a lower limb amputation because of late detection. The vulnerable individuals at risk of lower limb amputation are disproportionately racial and ethnic minorities. In particular, Black Americans are up to four times more likely to undergo an amputation than their Caucasian counterparts. Native Americans are more than twice as likely to be subjected to amputation, and Hispanic Americans are up to 75 percent more likely to have an amputation.

The ARC Act will fill the policy gap that allows these inequities to fester by increasing access to preventive screening and providing education to improve the early detection rate and prevent thousands of vulnerable beneficiaries from undergoing unnecessary amputations every year.

“We applaud Congressman Payne for his persistent leadership in addressing our nation’s health disparities and developing policy solutions to measurably prevent amputation,” said Dr. Eric J. DeLaura, an interventional radiologist and Medical Director of Image Guided Surgery & Aesthetics in Union, NJ. “We are now urging Congress to quickly pass the ARC Act and prevent thousands of Americans from undergoing needless amputation.”

Rep. Payne is co-sponsoring the ARC Act alongside Reps. Bobby Rush (IL-1) and Ruben Gallego (AZ-7).

###

CVC Commends Introduction of Bipartisan Bill to Protect Specialty Care from Severe Medicare Reimbursement Cuts

H.R. 8505 would block severe payment cuts to over 30 healthcare specialties including vascular surgery, cardiac surgery, interventional radiology and  interventional cardiology

Washington, D.C. –– The CardioVascular Coalition (CVC) – a consortium of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today praised House lawmakers for introducing H.R. 8505. The bipartisan bill, sponsored by Reps. Michael Burgess (TX-26) and Bobby Rush (IL-1) is intended to prevent severe Medicare reimbursement cuts to a slew of specialty providers from going into effect on January 1, 2021. By waiving budget neutrality rules for one year, the legislation would allow the Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) to allow scheduled evaluation and management (E/M) increases to go into effect without requiring Medicare to curtail reimbursements from 33 specialty providers, including vascular surgery, cardiac surgery, interventional radiology and interventional cardiology.

According to the CY2021 Physician Fee Schedule proposed rule issued in early August, CMS intends to cut vascular surgery by seven percent (-7%), cardiac surgery, by nine percent (-9%) and interventional radiology by nine percent (-9%) as well as interventional cardiology in order to offset the costs involved with increasing increases to E/M services. Unless Congress waives Medicare’s budget neutrality requirement, the deep cuts will go into effect on January 1, drastically increasing the financial strain that specialty providers face as they continue to deal with the fallout stemming from the ongoing COVID-19 public health emergency. In turn, the cuts threaten to seriously reduce Medicare beneficiaries’ access to these critical services—an outcome that would be devastating for America’s seniors.

“Patient access is paramount for proper treatment and amputation prevention for individuals with peripheral artery disease (PAD),” said Dr. Jeffrey Carr co-founder of the Outpatient Endovascular and Interventional Society (OEIS) and a member of the CVC. “At a time when the entire healthcare system is under unprecedented strain from the COVID-19 pandemic, it is completely irresponsible for CMS to push forward with severe specialty cuts that threaten to undermine Medicare beneficiaries’ access to dozens of critical services.”

“We applaud Reps. Burgess and Rush for their commitment to ensuring America’s seniors continue uninterrupted access to specialty care, and urge Congress to quickly pass the bipartisan H.R. 8505,” continued Dr. Carr.

A substantial number of bipartisan lawmakers have voiced concerns about Medicare’s proposed cuts and have called for budget neutrality requirements to be waived. In late September, more than 160 lawmakers, led by Representatives Roger Marshall (KS-1) and Bobby Rush (IL-1), sent a letter to CMS expressing deep concern about slashing support to specialty providers during the COVID-19 public health emergency.

###

CardioVascular Coalition Applauds Introduction of Legislation to Reduce Amputations, Improve Peripheral Artery Disease Awareness & Screening

Reps. Donald Payne, Jr., Bobby Rush and Ruben Gallego introduce Amputation Reduction and Compassion (ARC) Act to expand coverage for PAD screening and intervention

Washington, D.C. –– The CardioVascular Coalition (CVC) – a consortium of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today commended Reps. Donald Payne, Jr. (NJ-10), Bobby Rush (IL-1) and Ruben Gallego (AZ-7) for introducing a bill to reduce amputations while increasing education and testing for PAD. If passed, the Amputation Reduction and Compassion (ARC) Act (H.R. 8615) would provide coverage of PAD screening for at-risk beneficiaries under the Medicare and Medicaid programs without the imposition of cost-sharing requirements.

By expanding coverage for PAD screening such as the ankle-brachial index test for at-risk beneficiaries, the bill would help prevent vulnerable individuals from developing serious complications from PAD, which can lead to lower limb amputation. While an estimated 20 million Americans have PAD, many are unaware of the serious risks of the disease and are not encouraged to undergo preventative tests that could improve patient outcomes and reduce costs to the healthcare system. Unfortunately, an estimated 200,000 patients – a disproportionate number of whom are minorities – suffer avoidable amputations every year as a result of PAD.

The bill would prohibit the use of amputation without the completion of arterial testing to determine if alternative interventions could be applied. It would also establish a PAD education program to support, develop, and implement educational initiatives that inform health care professionals and the public about the existence of peripheral artery disease and methods to reduce amputations, particularly with respect to at-risk populations, such as racial and ethnic minorities who are more likely to face non-traumatic amputation than whites.

“By expanding coverage for simple, non-invasive screening tests, we have the power to help thousands of Americans avoid unnecessary amputations every year,” said Dr. Jeffrey Carr co-founder of the Outpatient Endovascular and Interventional Society (OEIS) and a member of the CVC. “We commend Reps. Payne, Rush and Gallego for introducing his critical legislation, which will go a long way toward saving lives and reducing racial and ethnic disparities in healthcare. With these goals in mind, we urge Congress to quickly pass the ARC Act.”

According to the Dartmouth Atlas, amputation risks for African Americans living with diabetes are as much as four times higher than the national average. Data analyses have similarly found that Native Americans are more than twice as likely to be subjected to amputation and Hispanics are up to 75 percent more likely to have an amputation.

“We look forward to working collaboratively with Reps. Payne, Rush and Gallego, and advocates across our profession, to build support for this pro-patient legislation, which is a giant step forward for the patients we serve and others at risk for PAD,” added Carr.

###

CardioVascular Coalition Urges Congress to Support Limb Loss Prevention During Peripheral Artery Disease (PAD) Awareness Month

Advocates call for policies to block planned specialty provider cuts before January 2021

Washington, DC – The CardioVascular Coalition (CVC), a leading group of providers, physicians, and manufacturers, today urged lawmakers in Congress to support policies to improve peripheral artery disease (PAD) screening, diagnoses and treatment to reduce unnecessary lower limb amputations in recognition of PAD Awareness Month.

Specifically, CVC is asking Congress to advance legislation to block planned Medicare payment cuts to specialty providers in 2021. In the Medicare Physician Fee Schedule (MPFS) Proposed Rule for 2021, the Centers for Medicare & Medicaid Services (CMS) plans to deeply cut payments to specialty providers – “vascular surgery” by seven percent (-7%), “cardiac surgery,” by nine percent (-9%) and “interventional radiology” by nine percent (-9%).

To mitigate these cuts, Congress must take steps to ensure Medicare waives the budget neutrality requirements for the E/M codes scheduled for implementation on January 1, 2021 in any relevant or upcoming legislation.

“As we recognize PAD Awareness Month this September, we urge policymakers to stop these harmful payment cuts to the specialty providers who screen, diagnose and perform interventional care to prevent limb loss,” said Dr. Jeffrey Carr, founding and past president of the Outpatient Endovascular and Interventional Society (OEIS) and a member of the CVC. “CMS should not proceed with any specialty provider cuts while we are in the middle of a public health crisis. Doing so will be harmful to both vulnerable older Americans and their healthcare providers.”

Bipartisan lawmakers agree. Last month a group of 93 House lawmakers sent a letter to House leadership asking them to waive budget neutrality in any relevant or upcoming legislation for Calendar Years 2021 and 2022 for the E/M codes scheduled for implementation on January 1, 2021.

Further, the CVC applauds efforts supported by the Congressional PAD Caucus, chaired by Congressmen Donald Payne, Jr. (D-NJ) and Gus Bilirakis (R-FL). The CVC is also a member of the PAD Task Force – alongside the Association of Black Cardiologists, Preventative Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions and Society of Interventional Radiology – which came together to advance a comprehensive strategy that combines increased public awareness and robust screening with non-amputation treatment measures and multidisciplinary care.

According to estimates, PAD affects nearly 20 million Americans and is responsible for 80 percent of the 200,000 non-traumatic limb amputations that take place in the U.S. each year. These non-traumatic amputations often occur without any diagnostic testing, meaning PAD patients are losing limbs before they receive testing to determine if limb-saving treatments are an option.

PAD is exacerbated by conditions like diabetes, chronic hypertension, and renal disease, which are most prevalent in minority populations. Access to revascularization therapies is especially vital to the African American, Hispanic and Native American populations who are two to four times more likely to undergo a limp amputation due to PAD because of increased prevalence of diabetes, obesity and other risk factors.

To learn more about PAD and PAD Awareness Month, CLICK HERE.

####

Radiology Business: Quash ‘reckless’ Medicare cuts that could cost radiology billions, lawmakers urge Congress

A bipartisan group of U.S. House members are asking congressional leaders to quash a Medicare payment change that could cost radiology billions in the years to come.

Spearheaded by Rep. Bobby Rush, D-Ill., the 92 lawmakers want Congress to waive budget-neutrality requirements stemming from a proposed pay increase for office-based evaluation and management services in 2021. Absent such a decision, the imaging industry stands to lose some $10 billion over the next decade, advocates estimate.

Click here to read the full article on the Radiology Business website. 

CardioVascular Coalition Commends Congressman Bobby Rush for Leading Effort of 93 Bipartisan Lawmakers to Block Medicare Specialty Cuts

Lawmakers call for policies to waive budget neutrality requirements in E/M codes and block planned specialty provider cuts before January 2021 

WASHINGTON – The CardioVascular Coalition (CVC) – a consortium of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today commended Congressman Bobby Rush (IL-1) and 92 of his bipartisan colleagues in the U.S. House for sending a letter to House leaders asking them to waive budget neutrality in any relevant or upcoming legislation for Calendar Years 2021 and 2022 for the E/M codes scheduled for implementation on January 1, 2021.

“If these cuts go into effect, they will be devastating for providers and will ultimately result in decreased access to care for patients.  Our healthcare system is already under tremendous financial strain, as it continues to grapple with both the economic and health consequences of the coronavirus. Now is not the time to implement these reckless cuts,” the bipartisan lawmakers write.

In the Medicare Physician Fee Schedule (MPFS) Proposed Rule for CY2021 issued on August 3, the Centers for Medicare & Medicaid Services (CMS) plans to deeply cut payments to specialty providers – including “vascular surgery,” “cardiac surgery,” and “interventional radiology” – in 2021. Specifically, Medicare plans to cut “vascular surgery” by seven percent (-7%), “cardiac surgery,” by nine percent (-9%) and “interventional radiology” by nine percent (-9%).

“We ask that, in any upcoming and relevant legislation moving through the House, you waive budget neutrality for Calendar Years 2021 and 2022 for the E/M codes scheduled for implementation on January 1, 2021 as described in the final rule (84. Fed. Reg. 62568, 62847-62860),” the lawmaker letter continues.

The CVC stressed that the impact of such deeps cuts would be magnified as a result of the COVID-19 public health emergency (PHE), particularly on minority populations who are at greatest risk for peripheral artery disease (PAD) and other forms of vascular disease, and whom have already suffered disproportionately from the COVID-19 crisis.

“We applaud Congressman Rush for his leadership on this issue and thank all 93 bipartisan lawmakers for lending their names to this important patient care issue,” said Dr. Jeffrey Carr, founding and past president of the Outpatient Endovascular and Interventional Society (OEIS) and a member of the CVC. “CMS should not proceed with any specialty provider cuts while we are in the middle of a public health crisis. Doing so will be harmful to both vulnerable older Americans and their healthcare providers.”

To read the letter to House leadership, click here.

###

CardioVascular Coalition Warns Deep Cuts to Specialty Services in Physician Fee Schedule Proposed Rule Will Restrict Patient Access to Limb-Saving Interventions

Congressional action needed to waive budget neutrality requirements in E/M codes and block planned specialty provider cuts before January 2021

WASHINGTON – The CardioVascular Coalition (CVC) – a consortium of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD) – today expressed disappointment in the Centers for Medicare & Medicaid Services (CMS) proposal to deeply cut Medicare payment for specialty providers – including “vascular surgery,” “cardiac surgery,” and “interventional radiology” – contained in the proposed Physician Fee Schedule Proposed Rule for CY2021. If finalized as proposed, these specialties will be cut by seven to nine percent in 2021.

According to the CVC, now is not the time for severe Medicare cuts on specialties providers who frequently care for patients living with vascular disease, including PAD, which disproportionally impacts African Americans and other minority populations who have been hardest hit by the COVID-19 pandemic. If left untreated with proper vascular intervention, PAD can result in lower-limb amputation.

“We are deeply disappointed in the agency’s proposal, which hits specialty providers at a time when we are already operating under severe financial stress due to the current public health crisis. Now is not that time to inflict new payment cuts,” said Dr. Jeffrey Carr, founding and past president of the Outpatient Endovascular and Interventional Society (OEIS) and a member of the CVC.

Lawmakers and healthcare stakeholders alike oppose these significant cuts.

In May, dozens of bipartisan members of the U.S. House of Representatives sent a letter to Congressional leaders asking them to include a waiver for the budget neutrality requirements included in the 2019 “evaluation and management” (E/M) code rule in any relevant legislation moving through Congress. By waiving the budget neutrality requirements, Congress can prevent the specialty cuts from taking effect while still allowing for the E/M payment increases.

In a letter sent on June 18 to congressional leaders, the CVC and more than a hundred stakeholder groups urged Senate Majority Leader Mitch McConnell and House Speaker Nancy Pelosi to help stop harmful payment cuts to specialty healthcare providers, including vascular and cardiac surgery. The CVC, alongside the American Medical Association and hundreds of other specialty provider groups, have advocated for Congress to stop the pending Medicare cuts to specialty providers by waiving budget neutrality for the E/M code proposal for 2021.

“We will now work with lawmakers in Congress to stop these potentially harmful cuts by securing provisions in future legislation to waive the budget neutrality requirement driving this cut, while also allowing increases to the E/M codes to go into effect,” added Carr.

###

PAD Task Force Welcomes Society of Interventional Radiology

PAD Task Force urges lawmakers to join Congressional PAD Caucus to advance policies to improve access to screening for at-risk populations and reduce preventable amputations

WASHINGTON – Members of the Peripheral Artery Disease (PAD) Task Force – including the Association of Black Cardiologists, CardioVascular Coalition, Preventative Cardiovascular Nurses Association and Society for Cardiovascular Angiography and Interventions – today welcomed the Society of Interventional Radiology (SIR). The PAD Task Force, originally formed in 2018, came together to advance a comprehensive strategy that combines increased public awareness and robust screening with non-amputation treatment measures and multidisciplinary care.

The Society of Interventional Radiology is a national organization of physicians, scientists and allied health professionals dedicated to improving public health through the use of minimally invasive therapeutic interventions for disease management, including PAD. SIR supports “legislative activities to raise awareness and improve the treatment of PAD.”

PAD is a limb-threatening circulatory condition, that when left undiagnosed and untreated can result in lower-limb amputation. It is exacerbated by conditions like diabetes, chronic hypertension, and renal disease, which are most prevalent in minority populations. According to estimates, PAD results in as many as 200,000 amputations annually in the United States. These non-traumatic amputations often occur without any diagnostic testing, meaning PAD patients are losing limbs before they receive the testing to determine if limb-saving treatments are an option.

In 2019, Congressmen Donald Payne, Jr. (D-NJ) and Gus Bilirakis (R-FL) formed the Congressional PAD Caucus to educate Congress and communities about PAD. Key priorities for the caucus include:

  • Increasing funding to raise awareness about PAD;
  • Improving access to PAD screening; and
  • Disallowing non-traumatic amputations without anatomical testing.

“We look forward to working with Congressmen Payne and Bilirakis, and members of the PAD Task Force,  to call attention to the devastating impact of PAD on communities across the country and advance a comprehensive strategy to combat PAD and reduce amputations in the United States that includes increased awareness of peripheral artery disease, increased screenings for at risk populations, and the avoidance of amputation of limbs without anatomical imaging,” said Michael D. Dake, MD, FSIR, SIR president and senior vice president of the University of Arizona Health Sciences in Tucson.

The PAD Task Force notes that its concerns around PAD are not restricted to government programs and urges private payers as well to adopt policies to raise awareness about PAD, improve access to PAD screening, and disallow non-traumatic amputations without anatomical testing.

###

AJMC: Why Amputations Are on the Rise in Some States, Even as Diabetes Care Improves

The last decade has brought great strides in diabetes care. Better insulins and better technology can allow people with diabetes—both type 1 and type 2—to keep their blood sugar from rising and falling in ways that cause long-term damage to their eyesight and vascular systems. New classes of drugs for patients with type 2 diabetes have been shown to cut the risk of heart and renal failure, and more widespread use could help some patients avoid dialysis.

But the good news is not felt by everyone. Amid this progress, the rate of amputations rose 50% between 2009 and 2015. African American patients lose limbs at triple the rate of other groups.

The mission of the Affordable Care Act—spend more to prevent disease and complications, and save money later—has bypassed many of these patients for one reason: they lack access to care. Fourteen states have not expanded Medicaid, including several Deep South states where diabetes and obesity rates are highest.

The result of these state-level policy decisions is becoming clear. Research presented at the recent meeting of the American Diabetes Association found a 17% decrease in the risk of amputation when patients lived in states that expanded Medicaid. What’s more, the number of hospital admissions for diabetic foot ulcers plummeted in states that expanded Medicaid, while rising 21% in states that rejected expansion.

None of this is news to Foluso Fakorede, MD, who treats patients at risk of limb loss in the Mississippi Delta. Fakorede spoke with The American Journal of Managed Care® about his work in Mississippi, through his practice, Cardiovascular Solutions of Central Mississippi.

Click here to see the full interview on the AJMC website. 

ProPublica Reporting Underscores Need for Improved PAD Screening for African Americans

CVC working collaboratively with bipartisan lawmakers to advance policies to improve access to screening for at-risk populations and reduce preventable amputations

WASHINGTON – The CardioVascular Coalition – a coalition of stakeholders and advocates created to improve awareness, prevention, and intervention of vascular disease including peripheral artery disease (PAD) – today stressed the importance of policies to support access to clinically appropriate PAD screening and treatment for America’s most at-risk patient populations in response to a new report, The Black American Amputation Epidemic, published by ProPublica.

The article profiles a community in the Mississippi Delta – primarily home to minority communities – and  the challenges individuals face accessing PAD screening and treatment, which results in the proliferation of unnecessary lower-limb amputations across the country.  The article highlights the need for the United States Preventive Services Task Force (USPSTF) to change their guidelines to recommend PAD screening of at-risk population. By recognizing that at-risk populations are more vulnerable to PAD than the general population, USPSTF could help to improve patient outcomes, reduce long-term healthcare costs, and eliminate racial disparities in PAD care.

Bipartisan lawmakers in Congress are also giving this issue attention. In 2019, Congressmen Donald Payne, Jr. (D-NJ) and Gus Bilirakis (R-FL) formed the Congressional PAD Caucus to educate Congress and communities about PAD while supporting legislative activities to improve PAD research, education, and treatment, with the goal of preventing non-traumatic amputations due to PAD and other related diseases. Key priorities for the caucus include:

  • U.S. Preventive Services Task Force should review screening for PAD for at-risk patients;
  • The Administration should form an intragovernmental work group to implement a comprehensive amputation prevention program for PAD patients in Medicare, the IHS and other federal programs;
  • Medicare should incentivize multidisciplinary review of PAD patients in Medicare; and
  • Medicare should disallow non-traumatic amputations without arterial testing.

CVC is also a member of the PAD Task Force, which was formed in 2018 to advance a comprehensive strategy that combines increased public awareness and robust screening with non-amputation treatment measures and multidisciplinary care.

PAD is a limb-threatening circulatory condition, that when left undiagnosed and untreated can result in lower-limb amputation. It is exacerbated by conditions like diabetes, chronic hypertension, and renal disease, which are most prevalent in minority populations. According to estimates, PAD results in as many as 200,000 amputations annually in the United States.

####

MedPage Today: COVID Could Cost Life and Limb — Literally

Amid the escalating volume of patients with COVID-19 in hospitals, doctors recently noticed something puzzling: the typical volume of patients with symptoms of heart attack, stroke, appendicitis, and other emergent or urgent health problems were no longer seeking care as frequently. As much as we wish that Americans are no longer suffering from these serious conditions, the reality is that these “missing” patients likely did not seek or have adequate access to care.

It’s an interesting (and somewhat frightening) byproduct of the coronavirus pandemic. Although health officials have been successful in keeping hospital inpatient beds and emergency departments open for surges of COVID-19 patients, some Americans who desperately need care are delaying it — or going without it altogether.

This situation is distressing, particularly for the estimated 20 million Americans suffering from limb-threatening conditions, such as peripheral artery disease, that require prompt intervention to prevent lower limb amputation. But the COVID-19 emergency, paired with looming Medicare cuts approved late last year, has created a uniquely troubling situation for Americans who need revascularization procedures — and the providers who care for them.

Click here to read the full article on the MedPage Today website.

Clarion Ledger: Amputations are soaring in the Delta among Black diabetics. One doctor is trying to end it

It was a Friday evening in the hospital after a particularly grueling week when Dr. Foluso Fakorede, the only cardiologist in Bolivar County, Mississippi, walked into Room 336. Henry Dotstry lay on a cot, his gray curls puffed on a pillow. Fakorede smelled the circumstances — a rancid whiff, like dead mice. He asked a nurse to undress the wound on Dotstry’s left foot, then slipped on nitrile gloves to examine the damage. Dotstry’s calf had swelled to nearly the size of his thigh. The tops of his toes were dark; his sole was yellow, oozing. Fakorede’s gut clenched.  F—, he thought.  It’s rotten.

Fakorede, who’d been asked to consult on the case, peeled off his gloves and read over Dotstry’s chart: He was 67, never smoked. His ultrasound results showed that the circulation in his legs was poor. Uncontrolled diabetes, it seemed, had constricted the blood flow to his foot, and without it, the infection would not heal. A surgeon had typed up his recommendation. It began: “Mr. Dotstry has limited options.”

Click here to see the full article on the Clarion Ledger website.

Mississippi Today: The black American amputation epidemic: Black patients losing limbs at triple the rate of others

IT WAS A FRIDAY EVENING in the hospital after a particularly grueling week when Dr. Foluso Fakorede, the only cardiologist in Bolivar County, Mississippi, walked into Room 336. Henry Dotstry lay on a cot, his gray curls puffed on a pillow. Fakorede smelled the circumstances — a rancid whiff, like dead mice. He asked a nurse to undress the wound on Dotstry’s left foot, then slipped on nitrile gloves to examine the damage. Dotstry’s calf had swelled to nearly the size of his thigh. The tops of his toes were dark; his sole was yellow, oozing. Fakorede’s gut clenched. Fuck, he thought. It’s rotten.

Click here to see the full article on the Mississippi Today website.

ProPublica: The Black American Amputation Epidemic

IT WAS A FRIDAY EVENING in the hospital after a particularly grueling week when Dr. Foluso Fakorede, the only cardiologist in Bolivar County, Mississippi, walked into Room 336. Henry Dotstry lay on a cot, his gray curls puffed on a pillow. Fakorede smelled the circumstances — a rancid whiff, like dead mice. He asked a nurse to undress the wound on Dotstry’s left foot, then slipped on nitrile gloves to examine the damage. Dotstry’s calf had swelled to nearly the size of his thigh. The tops of his toes were dark; his sole was yellow, oozing. Fakorede’s gut clenched. Fuck, he thought. It’s rotten.

Fakorede, who’d been asked to consult on the case, peeled off his gloves and read over Dotstry’s chart: He was 67, never smoked. His ultrasound results showed that the circulation in his legs was poor. Uncontrolled diabetes, it seemed, had constricted the blood flow to his foot, and without it, the infection would not heal. A surgeon had typed up his recommendation. It began: “Mr. Dotstry has limited options.”

 

Click here to read the full article on the ProPublica website.

National Kidney Month: Vascular Care Community Stresses PAD Risks in Patients with Chronic Kidney Disease

Minority populations with CKD are at a much higher risk than the general population of developing peripheral artery disease (PAD)

WASHINGTON – The Cardiovascular Coalition (CVC), a coalition of cardiovascular and endovascular care providers, physicians and manufacturers created to improve awareness, prevention, and intervention of vascular disease, urges increased awareness for kidney health and better understanding of related health conditions including Peripheral Artery Disease (PAD) in recognition of National Kidney Month.

Chronic Kidney Disease (CKD) is the ninth leading cause of death in the United States affecting an estimated 30 million American adults, a number that has been on the rise. Studies have shown that PAD is especially prevalent in patients with CKD, more so than the general population. PAD causes narrowing or blockage of the vessels that carry blood from the heart to the legs and other extremities and can eventually lead to amputation, if left untreated.

In the United States, approximately 20 million Americans have been diagnosed with PAD. Much like CKD, PAD disproportionately affects racial minorities due to higher prevalence of diabetes, limited access to appropriate clinical intervention and other underlying risk factors. The most at-risk groups for developing CKD, and eventually kidney failure, include African Americans, Hispanic and Native Americans, Pacific Islanders, and seniors. Similarly, elderly patients of color suffer from a disproportionately high rate of PAD.

“Understanding the correlation between PAD and CKD is especially critical for older Americans who often suffer from multiple comorbidities including hypertension and diabetes, which represent two of the most significant risk factors for these chronic conditions,” said Jeffrey G. Carr, MD, FACC. “I commend educational efforts to address general awareness and understanding of both CKD and PAD, especially by lawmakers in Congress who are ushering in policy change through both the Congressional Kidney Caucus and Congressional PAD Caucus.”

Studies have shown that patients with CKD are less likely to receive ‘optimal’ PAD care, underscoring the need for increased understanding of PAD by all stakeholders. Without the proper clinical care, PAD can lead to non-traumatic lower limb amputations, which data show lead to lower quality of life, increased mortality and higher healthcare costs.

“We look forward to our continued work with community stakeholders and bipartisan leaders in Congress to create a better understanding of PAD as well as public policies that encourage and support access to clinically-appropriate PAD screening and intervention, especially among our nation’s most at risk populations,” added Carr.

###

CardioVascular Coalition Commends Congress for Inclusion of Peripheral Artery Disease Language in End-of-Year Appropriations Package

WASHINGTON – The CardioVascular Coalition (CVC), a consortium of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD), today commended lawmakers in Congress for including language specific to peripheral artery disease education and awareness in Congress’ year-end legislative package. The appropriations language encourages the Centers and Disease Control and Prevention (CDC) to specifically focus on PAD.

The provision reads, “Peripheral Arterial Disease (PAD). – The agreement encourages CDC to support education and awareness activities that promote early diagnosis of PAD.”

Across the country, approximately 20 million Americans have been diagnosed with PAD, including 1 in 20 Americans over the age of 50. PAD is a vascular disease, which left undiagnosed and untreated can lead to lower limb amputation. Research shows that ethnic and racial minorities have a substantially greater risk of developing PAD and requiring amputations than their white counterparts. For example, African American patients with diabetes are more than three times as likely to have their limbs surgically removed than their white counterparts.

Earlier this year, Congressman Payne – alongside Congressman Gus Bilirakis (R-FL-12) – launched a new Congressional PAD Caucus to educate Congress and communities about PAD while supporting legislative activities to improve PAD research, education, and treatment, with the goal of preventing non-traumatic amputations due to PAD and other related diseases.

The CVC will continue to work with bipartisan lawmakers in Congress on PAD issues in 2020 to advance additional policy efforts to increase awareness and understanding of PAD with the ultimate goal of improving patient outcomes and reducing amputations.

###

CardioVascular Coalition Releases New White Paper on Value of Peripheral Artery Disease Screening Among At-Risk Populations

CVC urges USPSTF to update PAD screening recommendations to include at-risk populations to prevent amputation, reduce healthcare costs, and eliminate racial disparities

WASHINGTON – The CardioVascular Coalition (CVC), a consortium of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD), released a new white paper urging the United States Preventative Services Task Force (USPSTF) to revisit its PAD screening recommendation guidelines. The white paper, Mind the Gap: The Case for Screening High-Risk Communities for PAD, argues recommendations should be updated to ensure Americans at high risk of developing the disease have better access to screening, which has been shown to significantly improve patient outcomes by preventing amputation.

The USPSTF has consistently found “insufficient evidence to assess the balance of benefits and harms” of the ankle-brachial index (ABI) screening methodology. However, this assessment is flawed because the USPSTF focused its guidelines on PAD screening for the general population (i.e. Americans of all ages, ethnic and racial backgrounds, socioeconomic status, and health histories), while ignoring the increased risk factors that certain populations face. This conclusion makes it significantly less likely that minorities, people with a history of diabetes or cardiovascular disease, and individuals in high-risk communities will be screened for PAD until it is too late to save their limbs.

Screening and early detection has been shown to reduce the probability of an amputation due to PAD by 90 percent but is greatly underutilized, as only 12.5 percent of patients with PAD are identified by physicians and treated. Overall, a majority of the estimated 200,000 annual non-traumatic amputations that occur in the United States every year can be avoided with the proper care.

Across the country, approximately 20 million Americans have been diagnosed with PAD, including 1 in 20 Americans over the age of 50. When common risk factors such as diabetes and nicotine use are included in the analysis of prevalence, as many as one-third of patients are estimated to suffer from the disease. Similarly, more than 30 million Americans with diabetes and an additional 84.1 million Americans with prediabetes are at an elevated risk of developing PAD in their lifetimes.

Moreover, a growing body of research shows that ethnic and racial minorities have a substantially greater risk of developing PAD and requiring amputations than their white counterparts. For example, African American patients with diabetes are more than three times as likely to have their limbs surgically removed than their white counterparts. Native Americans in the western U.S. are twice as likely to suffer from PAD than white Americans, while Hispanics are 75 percent more likely to develop the disease. While all older Americans tend to be more susceptible to PAD than younger Americans, elderly patients of color suffer from a disproportionately high rate of PAD.

In the white paper, CVC urges the USPSTF to revisit its recommendation on PAD screening and review the data as it relates to PAD screening for at-risk populations, including those with a history of smoking, diabetes, and other cardiovascular diseases. By recognizing that at-risk populations are more vulnerable to PAD than the general population, USPSTF should seize the opportunity to improve patient outcomes, reduce long-term healthcare costs, and eliminate racial disparities in the cardiovascular space.

To read Mind the Gap: The Case for Screening High-Risk Communities for PAD, click here.

###

CVC Stresses Importance of Understanding Peripheral Artery Disease (PAD) Risks During American Diabetes Month

Because diabetes is a primary risk factor for PAD, patient education and screening of at-risk populations is critical to reducing lower limb amputations

WASHINGTON – In recognition of American Diabetes Month, which starts on November 1, the Cardiovascular Coalition (CVC), a consortium of physicians, care providers, advocates, and manufacturers working to improve awareness and prevention of peripheral artery disease (PAD), encourages Americans living with diabetes and pre-diabetes to learn more about their risks for PAD.

More than 30 million Americans with diabetes and an additional 84.1 million Americans with prediabetes are at an elevated risk of developing PAD, which causes severe leg pain and often leads to multiple complications including gangrene, diabetic foot ulcers, and amputation if left untreated. PAD, which causes an estimated 85 percent of the 200,000 non-traumatic limb amputations in the U.S. each year, disproportionally impacts minority populations. It is caused by a build-up of fatty deposits in a person’s arteries over time and because high blood glucose can damage blood vessels, diabetes is considered a primary risk factor for PAD.

Early PAD screening among at-risk populations has been shown to reduce the probability of an amputation resulting from PAD by 90 percent, but is greatly underutilized as only 12.5 percent of PAD cases are identified by doctors and treated. Overall, many of the non-traumatic amputations that occur in the United States each year could be avoided with the proper clinical intervention and treatment.

Unfortunately, screening for PAD is still not commonplace, even amongst at-risk patients. Despite the clear risks, the U.S. Preventative Services Task Force (USPSTF) released guidelines that conclude “the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease and cardiovascular disease risk with the ankle-brachial index (ABI) in asymptomatic adults.” Unfortunately, by making recommendations for the general public—as opposed to at-risk individuals and communities— the USPSTF’s guidelines do a disservice to at-risk patients.

Instead, the American College of Cardiology and American Heart Association joint practice guidelines recommend PAD screening for high-risk patients.

Lawmakers in Congress are also drawing attention to the importance of understanding PAD. Earlier this year, bipartisan lawmakers in the U.S. House of Representatives launched a Congressional PAD Caucus to educate Congress and communities about PAD while supporting legislative activities to improve PAD research, education, and treatment, with the goal of preventing non-traumatic amputations due to PAD and other related diseases.  As part of their policy agenda to support our goal of preventing amputations, the caucus is urging the USPSTF to review screening for PAD for at-risk patients.

“In recognition of American Diabetes Month, Americans with diabetes and prediabetes are encouraged to talk to their doctor about their risks for PAD, which can help them avoid dangerous complications including amputation,” said Dr. Jeffrey Carr, MD, FACC, founding and immediate past president of the Outpatient Endovascular and Interventional Society and a member of the CVC . “We look forward to working with lawmakers in the Congressional PAD Caucus to advance policies that ensure patient access to clinically appropriate PAD care to prevent limb loss, improve lives, and reduce healthcare costs.”

###